TNIK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| O00203 | T424 | Sugiyama | AP3B1 ADTB3A | TLLREFQTYVKSQDKQFAAAtIQtIGRCATNILEVTDTCLN |
| O00203 | T427 | Sugiyama | AP3B1 ADTB3A | REFQTYVKSQDKQFAAAtIQtIGRCATNILEVTDTCLNGLV |
| O00571 | T156 | Sugiyama | DDX3X DBX DDX3 | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGNNCP |
| O14744 | T80 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | KNRPGPQTRSDLLLSGRDWNtLIVGKLSPWIRPDSKVEKIR |
| O14908 | T238 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | FDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPs |
| O14908 | T242 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | SQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPsAFEE |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15067 | T591 | Sugiyama | PFAS KIAA0361 | NRDFLTHVSARERCPACFVGtITGDRRIVLVDDRECPVRRN |
| O15523 | T154 | Sugiyama | DDX3Y DBY | WSKPLPPSERLEQELFsGGNtGINFEKYDDIPVEATGSNCP |
| O43175 | S14 | Sugiyama | PHGDH PGDH3 | _______MAFANLRKVLIsDsLDPCCRKILQDGGLQVVEKQ |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43242 | T69 | Sugiyama | PSMD3 | GEADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGK |
| O43242 | T71 | Sugiyama | PSMD3 | ADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGKEP |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T509 | Sugiyama | ACTN4 | HNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQL |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O75369 | T1444 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGPRG |
| O75390 | T335 | Sugiyama | CS | LQKEVGKDVSDEKLRDYIWNtLNSGRVVPGyGHAVLRKTDP |
| O75436 | T102 | Sugiyama | VPS26A VPS26 | KSNTHEFVNLVKELALPGELtQSRSYDFEFMQVEKPYESYI |
| O94776 | S433 | Sugiyama | MTA2 MTA1L1 PID | ATRGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQt |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O95260 | S503 | Sugiyama | ATE1 | GVYKKQQKDPSEEAAVLQYAsLVGQKCSERMLLFRN_____ |
| O95373 | T997 | Sugiyama | IPO7 RANBP7 | yQALTHGLNEEQRKQLQDIAtLADQRRAAHESKMIEKHGGY |
| O95433 | T20 | Sugiyama | AHSA1 C14orf3 HSPC322 | _MAKWGEGDPRWIVEERADAtNVNNWHWtERDASNWSTDKL |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95817 | Y240 | Sugiyama | BAG3 BIS | AAQPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPL |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | S69 | Sugiyama | LDHA PIG19 | ALVDVIEDKLKGEMMDLQHGsLFLRTPKIVSGKDyNVTANs |
| P00338 | T275 | Sugiyama | LDHA PIG19 | SVADLAESIMKNLRRVHPVstMIKGLYGIKDDVFLSVPCIL |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | T202 | Sugiyama | PNP NP | GEQRELQEGTYVMVAGPSFEtVAECRVLQKLGADAVGMSTV |
| P00505 | T186 | Sugiyama | GOT2 KYAT4 | tPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDISKIPEQSV |
| P00505 | T192 | Sugiyama | GOT2 KYAT4 | AGMQLQGyRYYDPKtCGFDFtGAVEDISKIPEQSVLLLHAC |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00568 | T39 | Sugiyama | AK1 | SGKGTQCEKIVQKyGytHLstGDLLRSEVSSGSARGKKLsE |
| P00568 | Y34 | Sugiyama | AK1 | VGGPGSGKGTQCEKIVQKyGytHLstGDLLRSEVSSGSARG |
| P00966 | S92 | Sugiyama | ASS1 ASS | FIWPAIQSSALYEDRYLLGtsLARPCIARKQVEIAQREGAK |
| P00966 | T91 | Sugiyama | ASS1 ASS | EFIWPAIQSSALYEDRYLLGtsLARPCIARKQVEIAQREGA |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | S361 | Sugiyama | TFRC | AAEKLFGNMEGDCPSDWKTDstCRMVTSESKNVKLTVSNVL |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04083 | T136 | Sugiyama | ANXA1 ANX1 LPC1 | AQFDADELRAAMKGLGtDEDtLIEILAsRtNKEIRDINRVY |
| P04083 | T145 | Sugiyama | ANXA1 ANX1 LPC1 | AAMKGLGtDEDtLIEILAsRtNKEIRDINRVYREELKRDLA |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04083 | Y230 | Sugiyama | ANXA1 ANX1 LPC1 | GERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKHDMNK |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T153 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | MGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEG |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05362 | T436 | Sugiyama | ICAM1 | TPMCQAWGNPLPELKCLKDGtFPLPIGEsVtVtRDLEGtyL |
| P05362 | T446 | Sugiyama | ICAM1 | LPELKCLKDGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEV |
| P05388 | T122 | Sugiyama | RPLP0 | LLANKVPAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALG |
| P05388 | T128 | Sugiyama | RPLP0 | PAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALGItTKIS |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | T123 | Sugiyama | SSB | EyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNIQMR |
| P05783 | T404 | Sugiyama | KRT18 CYK18 PIG46 | LEDGEDFNLGDALDssNsMQtIQKtTTRRIVDGKVVsETND |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S258 | Sugiyama | KRT8 CYK8 | QISDTSVVLsMDNSRsLDMDsIIAEVKAQyEDIANRsRAEA |
| P06576 | T334 | Sugiyama | ATP5F1B ATP5B ATPMB ATPSB | AGsEVsALLGRIPSAVGYQPtLATDMGtMQERITTTKKGSI |
| P06576 | T341 | Sugiyama | ATP5F1B ATP5B ATPMB ATPSB | LLGRIPSAVGYQPtLATDMGtMQERITTTKKGSITSVQAIY |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T117 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | RGyPtIKFFRNGDTASPKEytAGREADDIVNWLKKRTGPAA |
| P07339 | T334 | Sugiyama | CTSD CPSD | AIGAVPLIQGEYMIPCEKVstLPAItLKLGGKGYKLsPEDY |
| P07339 | T339 | Sugiyama | CTSD CPSD | PLIQGEYMIPCEKVstLPAItLKLGGKGYKLsPEDYTLKVs |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07737 | S133 | Sugiyama | PFN1 | LMGKEGVHGGLINKKCyEMAsHLRRsQY_____________ |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07814 | T707 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | VsPysCKEAPCVLIyIPDGHtKEMPTSGSKEKTKVEATKNE |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P07900 | T65 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQ |
| P07900 | T88 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | sKLDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| P07900 | T90 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P07900 | T94 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtIAKSG |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T60 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P09923 | Y179 | Sugiyama | ALPI | GKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQ |
| P09960 | T507 | Sugiyama | LTA4H LTA4 | FNAtDLKDLsSHQLNEFLAQtLQRAPLPLGHIKRMQEVYNF |
| P09972 | T119 | Sugiyama | ALDOC ALDC | QDKGIVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYK |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S383 | Sugiyama | HSPD1 HSP60 | DKAQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGVAV |
| P10809 | T173 | Sugiyama | HSPD1 HSP60 | AELKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKV |
| P10809 | T206 | Sugiyama | HSPD1 HSP60 | IsDAMKKVGRKGVITVKDGKtLNDELEIIEGMKFDRGyIsP |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T320 | Sugiyama | HSPD1 HSP60 | VKAPGFGDNRKNQLKDMAIAtGGAVFGEEGLtLNLEDVQPH |
| P10809 | T331 | Sugiyama | HSPD1 HSP60 | NQLKDMAIAtGGAVFGEEGLtLNLEDVQPHDLGKVGEVIVt |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S432 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTKD |
| P11142 | T158 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | tVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T222 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFI |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T313 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYTSITRARFEELNADLFRGtLDPVEKALRDAKLDKsQIHD |
| P11142 | T425 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TAGGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEG |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P11940 | T71 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | sLGyAyVNFQQPADAERALDtMNFDVIKGKPVRIMWSQRDP |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12268 | S505 | Sugiyama | IMPDH2 IMPD2 | SGELKFEKRtssAQVEGGVHsLHsyEKRLF___________ |
| P12268 | T252 | Sugiyama | IMPDH2 IMPD2 | DYPLASKDAKKQLLCGAAIGtHEDDKYRLDLLAQAGVDVVV |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12270 | T1039 | Sugiyama | TPR | QDDKRRAIESMEQQLSELKKtLSSVQNEVQEALQRASTALS |
| P12814 | T426 | Sugiyama | ACTN1 | HEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDLAA |
| P12814 | T490 | Sugiyama | ACTN1 | PsVNARCQKICDQWDNLGALtQKRREALERTEKLLETIDQL |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P13010 | T472 | Sugiyama | XRCC5 G22P2 | NAVDALIDSMSLAKKDEKTDtLEDLFPTTKIPNPRFQRLFQ |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13639 | T486 | Sugiyama | EEF2 EF2 | CGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPVVR |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13796 | T174 | Sugiyama | LCP1 PLS2 | FNAVGDGIVLCKMINLSVPDtIDERTINKKKLTPFTIQENL |
| P13797 | T177 | Sugiyama | PLS3 | FKAVGDGIVLCKMINLSVPDtIDERAINKKKLTPFIIQENL |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14314 | T489 | Sugiyama | PRKCSH G19P1 | tGCWQGPNRstTVRLLCGKEtMVtStTEPSRCEYLMELMTP |
| P14314 | T492 | Sugiyama | PRKCSH G19P1 | WQGPNRstTVRLLCGKEtMVtStTEPSRCEYLMELMTPAAC |
| P14314 | T494 | Sugiyama | PRKCSH G19P1 | GPNRstTVRLLCGKEtMVtStTEPSRCEYLMELMTPAACPE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14649 | T101 | Sugiyama | MYL6B MLC1SA | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDELKSRR |
| P15259 | T96 | Sugiyama | PGAM2 PGAMM | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQVKIWR |
| P15311 | T299 | Sugiyama | EZR VIL2 | RILQLCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T224 | Sugiyama | RPS2 RPS4 | IVsAPVPKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAI |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P16083 | T59 | Sugiyama | NQO2 NMOR2 | VSDLyAMNLEPRATDKDITGtLSNPEVFNyGVEtHEAyKQR |
| P16083 | T72 | Sugiyama | NQO2 NMOR2 | TDKDITGtLSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKV |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17174 | T110 | Sugiyama | GOT1 | GDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNGTNNK |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P18621 | S142 | Sugiyama | RPL17 | APKMRRRTYRAHGRINPyMssPCHIEMILtEKEQIVPKPEE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | T12 | Sugiyama | RPL17 | _________MVRysLDPENPtKsCKSRGSNLRVHFKNtRET |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P18669 | T96 | Sugiyama | PGAM1 PGAMA CDABP0006 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S595 | Sugiyama | NCL | FVKGLsEDttEEtLKEsFDGsVRARIVTDRETGssKGFGFV |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P19338 | T587 | Sugiyama | NCL | RSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDRETG |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20073 | T203 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | ANFDAIRDAEILRKAMKGFGtDEQAIVDVVANRsNDQRQKI |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22234 | S223 | Sugiyama | PAICS ADE2 AIRC PAIS | IVLADVIDNDsWRLWPSGDRsQQKDKQSYRDLKEVtPEGLQ |
| P22314 | T668 | Sugiyama | UBA1 A1S9T UBE1 | ARDEFEGLFKQPAENVNQyLtDPKFVERtLRLAGtQPLEVL |
| P22314 | T682 | Sugiyama | UBA1 A1S9T UBE1 | NVNQyLtDPKFVERtLRLAGtQPLEVLEAVQRSLVLQRPQT |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22626 | S201 | Sugiyama | HNRNPA2B1 HNRPA2B1 | NAEVRKALsRQEMQEVQssRsGRGGNFGFGDsRGGGGNFGP |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23381 | S378 | Sugiyama | WARS1 IFI53 WARS WRS | sIFLtDtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDV |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23921 | T120 | Sugiyama | RRM1 RR1 | DLyNyINPHNGKHSPMVAKstLDIVLANKDRLNsAIIYDRD |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25705 | T225 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GQRELIIGDRQTGKTSIAIDtIINQKRFNDGsDEKKKLyCI |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T299 | Sugiyama | MSN | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQME |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26447 | T15 | Sugiyama | S100A4 CAPL MTS1 | ______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSELK |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26639 | T704 | Sugiyama | TARS1 TARS | GTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEEF_ |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P26641 | T411 | Sugiyama | EEF1G EF1G PRO1608 | QVDyESyTWRKLDPGsEEtQtLVREyFSWEGAFQHVGKAFN |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | T173 | Sugiyama | CALR CRTC | KNVLINKDIRCKDDEFTHLytLIVRPDNtyEVKIDNsQVEs |
| P27797 | T181 | Sugiyama | CALR CRTC | IRCKDDEFTHLytLIVRPDNtyEVKIDNsQVEsGsLEDDWD |
| P28066 | T161 | Sugiyama | PSMA5 | LLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQssL |
| P29401 | S124 | Sugiyama | TKT | ssDLDGHPVPKQAFtDVATGsLGQGLGAACGMAYTGKYFDK |
| P29401 | T118 | Sugiyama | TKT | LNLRKIssDLDGHPVPKQAFtDVATGsLGQGLGAACGMAYT |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S109 | Sugiyama | PEBP1 PBP PEBP | VVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyEQDR |
| P30086 | S98 | Sugiyama | PEBP1 PBP PEBP | DPKYREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLH |
| P30086 | T115 | Sugiyama | PEBP1 PBP PEBP | NDIssGtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDE |
| P30101 | S478 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKK |
| P30419 | T122 | Sugiyama | NMT1 NMT | GQGPAKTMEEASKRSyQFWDtQPVPKLGEVVNtHGPVEPDK |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P31153 | T240 | Sugiyama | MAT2A AMS2 MATA2 | DALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAG |
| P31153 | T262 | Sugiyama | MAT2A AMS2 MATA2 | yHLQPsGRFVIGGPQGDAGLtGRKIIVDTYGGWGAHGGGAF |
| P31327 | T206 | Sugiyama | CPS1 | EGQPVDFVDPNKQNLIAEVstKDVKVYGKGNPTKVVAVDCG |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31943 | T287 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | CFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIyN |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P33176 | T809 | Sugiyama | KIF5B KNS KNS1 | VAKELQTLHNLRKLFVQDLAtRVKKSAEIDsDDTGGsAAQK |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34932 | T758 | Sugiyama | HSPA4 APG2 HSPH2 | TNEAMEWMNNKLNLQNKQsLtMDPVVKSKEIEAKIKELTst |
| P35241 | T299 | Sugiyama | RDX | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P35268 | T62 | Sugiyama | RPL22 | FLQERIKVNGKAGNLGGGVVtIERsKSKITVTSEVPFSKRY |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35579 | T1764 | Sugiyama | MYH9 | NtELINDRLKKANLQIDQINtDLNLERSHAQKNENARQQLE |
| P35579 | T309 | Sugiyama | MYH9 | KTDLLLEPyNKyRFLsNGHVtIPGQQDKDMFQETMEAMRIM |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T23 | Sugiyama | RPL4 RPL1 | CARPLISVysEKGESSGKNVtLPAVFKAPIRPDIVNFVHTN |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | S84 | Sugiyama | SRP14 | KKKISTVVSSKEVNKFQMAysNLLRANMDGLKKRDKKNKTK |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39023 | T189 | Sugiyama | RPL3 OK/SW-cl.32 | RLLPLRQKKAHLMEIQVNGGtVAEKLDWARERLEQQVPVNQ |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40261 | S213 | Sugiyama | NNMT | LVIMDALKSSYYMIGEQKFSsLPLGREAVEAAVKEAGYTIE |
| P40763 | T389 | Sugiyama | STAT3 APRF | DKDSGDVAALRGSRKFNILGtNTKVMNMEESNNGSLSAEFK |
| P40925 | S141 | Sugiyama | MDH1 MDHA | KKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCLtRLDHN |
| P40925 | T139 | Sugiyama | MDH1 MDHA | YAKKSVKVIVVGNPANtNCLtAsKSAPSIPKENFsCLtRLD |
| P40925 | T225 | Sugiyama | MDH1 MDHA | KEVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMS |
| P40926 | T224 | Sugiyama | MDH2 | TIIPLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGA |
| P40926 | T227 | Sugiyama | MDH2 | PLISQCtPKVDFPQDQLtALtGRIQEAGtEVVKAKAGAGsA |
| P41091 | T41 | Sugiyama | EIF2S3 EIF2G | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| P41091 | T46 | Sugiyama | EIF2S3 EIF2G | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHt |
| P41223 | T115 | Sugiyama | BUD31 EDG2 | QGYENLCCLRCIQTRDtNFGtNCICRVPKSKLEVGRIIECT |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42858 | S13 | PSP | HTT HD IT15 | ________MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQ |
| P42858 | T3 | PSP | HTT HD IT15 | __________________MAtLEKLMKAFEsLKsFQQQQQQ |
| P43034 | T139 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | VFSVMVSASEDATIKVWDyEtGDFERtLKGHtDsVQDIsFD |
| P43034 | T145 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | SASEDATIKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLL |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | T95 | Sugiyama | RPL27A | LDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRsGyyKVLGKG |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46779 | T80 | Sugiyama | RPL28 | VVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKN |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46782 | T73 | Sugiyama | RPS5 | AGRYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIV |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46783 | T93 | Sugiyama | RPS10 | NEGIQYLRDyLHLPPEIVPAtLRRSRPETGRPRPKGLEGER |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47897 | T518 | Sugiyama | QARS1 QARS | KILQLVATGAVRDWDDPRLFtLtALRRRGFPPEAINNFCAR |
| P47897 | T520 | Sugiyama | QARS1 QARS | LQLVATGAVRDWDDPRLFtLtALRRRGFPPEAINNFCARVG |
| P47914 | T155 | Sugiyama | RPL29 | AQAAAPAsVPAQAPKRtQAPtKAsE________________ |
| P48643 | T47 | Sugiyama | CCT5 CCTE KIAA0098 | RLMGLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGD |
| P48643 | T50 | Sugiyama | CCT5 CCTE KIAA0098 | GLEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtV |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T2230 | Sugiyama | FASN FAS | LAQQQtQLNLRSLLVNPEGPtLMRLNsVQssERPLFLVHPI |
| P49327 | T295 | Sugiyama | FASN FAS | SLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGItRALCAt |
| P49368 | T430 | Sugiyama | CCT3 CCTG TRIC5 | GGGASEMAVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRT |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49736 | T857 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KQLVAEQVTyQRNRFGAQQDtIEVPEKDLVDKARQINIHNL |
| P49773 | T17 | Sugiyama | HINT1 HINT PKCI1 PRKCNH1 | ____MADEIAKAQVARPGGDtIFGKIIRKEIPAKIIFEDDR |
| P49902 | S418 | Sugiyama | NT5C2 NT5B NT5CP PNT5 | FLAELYKHLDssSNERPDIssIQRRIKKVTHDMDMCYGMMG |
| P50395 | T205 | Sugiyama | GDI2 RABGDIB | TGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsPYL |
| P50914 | T43 | Sugiyama | RPL14 | KLVAIVDVIDQNRALVDGPCtQVRRQAMPFKCMQLTDFILK |
| P50990 | S161 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAK |
| P50990 | S162 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAKL |
| P50990 | T374 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EVGDTQVVVFKHEKEDGAIstIVLRGstDNLMDDIERAVDD |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51153 | S164 | Sugiyama | RAB13 GIG4 | GIRFFETSAKSsMNVDEAFSsLARDILLKSGGRRsGNGNKP |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P52272 | S633 | Sugiyama | HNRNPM HNRPM NAGR1 | GGGGAsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKAC |
| P52272 | S637 | Sugiyama | HNRNPM HNRPM NAGR1 | AsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKACQIFV |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P54652 | T225 | Sugiyama | HSPA2 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55010 | T235 | Sugiyama | EIF5 | RMDEISDHAKVLtLsDDLERtIEERVNILFDFVKKKKEEGV |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P56192 | S127 | Sugiyama | MARS1 MARS | GKKGEDVLGSVRRALTHIDHsLSRQNCPFLAGETESLADIV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T44 | Sugiyama | MYL6 | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDEMNVKV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T229 | Sugiyama | ACTB | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | T80 | Sugiyama | EIF4A1 DDX2A EIF4A | QRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDLKA |
| P61160 | T15 | Sugiyama | ACTR2 ARP2 | ______MDSQGRKVVVCDNGtGFVKCGYAGSNFPEHIFPAL |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | T80 | Sugiyama | RPL15 EC45 TCBAP0781 | VIyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQs |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61769 | T106 | Sugiyama | B2M CDABP0092 HDCMA22P | YYTEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_______ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T210 | Sugiyama | YWHAG | PEQACHLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNL |
| P62191 | T292 | Sugiyama | PSMC1 | RVAEEHAPSIVFIDEIDAIGtKRYDSNSGGEREIQRTMLEL |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62312 | T75 | Sugiyama | LSM6 | QLKNKyGDAFIRGNNVLyIstQKRRM_______________ |
| P62314 | T57 | Sugiyama | SNRPD1 | NTHLKAVKMTLKNREPVQLEtLsIRGNNIRYFILPDsLPLD |
| P62333 | T104 | Sugiyama | PSMC6 SUG2 | RRQLDKSKLKPGTRVALDMTtLtIMRYLPREVDPLVYNMsH |
| P62333 | T106 | Sugiyama | PSMC6 SUG2 | QLDKSKLKPGTRVALDMTtLtIMRYLPREVDPLVYNMsHED |
| P62424 | T142 | Sugiyama | RPL7A SURF-3 SURF3 | AAGKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVD |
| P62424 | T144 | Sugiyama | RPL7A SURF-3 SURF3 | GKGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPI |
| P62424 | T145 | Sugiyama | RPL7A SURF-3 SURF3 | KGDVPTKRPPVLRAGVNtVttLVENKKAQLVVIAHDVDPIE |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T24 | Sugiyama | RAN ARA24 OK/SW-cl.81 | QGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLG |
| P62826 | T25 | Sugiyama | RAN ARA24 OK/SW-cl.81 | GEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGV |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62851 | T113 | Sugiyama | RPS25 | sKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA________ |
| P62851 | Y109 | Sugiyama | RPS25 | QELLsKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA____ |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62913 | T44 | Sugiyama | RPL11 | ICVGEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRR |
| P62913 | T47 | Sugiyama | RPL11 | GEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEK |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T15 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______MGVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGK |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T226 | Sugiyama | YWHAZ | LsEEsyKDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_ |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T229 | Sugiyama | ACTG1 ACTG | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00796 | T75 | Sugiyama | SORD | GRIGNFIVKKPMVLGHEAsGtVEKVGSSVKHLKPGDRVAIE |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01518 | T165 | Sugiyama | CAP1 CAP | AMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVKA |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | T168 | Sugiyama | RPL18A | SKIKFPLPHRVLRRQHKPRFttKRPNtFF____________ |
| Q02543 | T169 | Sugiyama | RPL18A | KIKFPLPHRVLRRQHKPRFttKRPNtFF_____________ |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07157 | T1167 | Sugiyama | TJP1 ZO1 | EQAPRAsALRHEEQPAPGyDtHGRLRPEAQPHPsAGPKPAE |
| Q08J23 | S322 | Sugiyama | NSUN2 SAKI TRM4 | IATRGAEQLAEGGRMVYSTCsLNPIEDEAVIASLLEKSEGA |
| Q12931 | T641 | Sugiyama | TRAP1 HSP75 HSPC5 | FLRMQQLAKTQEERAQLLQPtLEINPRHALIKKLNQLRASE |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13283 | T248 | Sugiyama | G3BP1 G3BP | QKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVT |
| Q13310 | T71 | Sugiyama | PABPC4 APP1 PABP4 | sLGyAyVNFQQPADAERALDtMNFDVIKGKPIRIMWSQRDP |
| Q13347 | T201 | Sugiyama | EIF3I EIF3S2 TRIP1 | LVNVKEHSRQINDIQLsRDMtMFVtASKDNTAKLFDsttLE |
| Q13347 | T205 | Sugiyama | EIF3I EIF3S2 TRIP1 | KEHSRQINDIQLsRDMtMFVtASKDNTAKLFDsttLEHQKT |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T312 | Sugiyama | TUBB3 TUBB4 | QMFDAKNMMAACDPRHGRYLtVAtVFRGRMSMKEVDEQMLA |
| Q13509 | T315 | Sugiyama | TUBB3 TUBB4 | DAKNMMAACDPRHGRYLtVAtVFRGRMSMKEVDEQMLAIQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13765 | T214 | Sugiyama | NACA HSD48 | KAVRALKNNSNDIVNAIMELtM___________________ |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14103 | T91 | Sugiyama | HNRNPD AUF1 HNRPD | sKNEEDEGHsNssPRHsEAAtAQREEWKMFIGGLSWDTTKK |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14240 | T81 | Sugiyama | EIF4A2 DDX2B EIF4F | QRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEFKE |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14683 | T638 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | VCDNVEDARRIAFGGHQRHKtVALDGtLFQKsGVISGGASD |
| Q14683 | T644 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | DARRIAFGGHQRHKtVALDGtLFQKsGVISGGASDLKAKAR |
| Q14914 | T83 | Sugiyama | PTGR1 LTB4DH | MMGQQVAKVVESKNVALPKGtIVLAsPGWttHSISDGKDLE |
| Q14914 | T92 | Sugiyama | PTGR1 LTB4DH | VESKNVALPKGtIVLAsPGWttHSISDGKDLEKLLTEWPDT |
| Q14974 | S201 | Sugiyama | KPNB1 NTF97 | MRKEEPSNNVKLAAtNALLNsLEFTKANFDKESERHFIMQV |
| Q14974 | T195 | Sugiyama | KPNB1 NTF97 | TAIIQGMRKEEPSNNVKLAAtNALLNsLEFTKANFDKESER |
| Q14974 | T860 | Sugiyama | KPNB1 NTF97 | RPMIHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA____ |
| Q14974 | T863 | Sugiyama | KPNB1 NTF97 | IHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA_______ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15075 | T235 | Sugiyama | EEA1 ZFYVE2 | LQRPGIEDVAVLKKELVQVQtLMDNMtLERERESEKLKDEC |
| Q15075 | T241 | Sugiyama | EEA1 ZFYVE2 | EDVAVLKKELVQVQtLMDNMtLERERESEKLKDECKKLQSQ |
| Q15084 | T100 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPEDYQGGRTG |
| Q15084 | Y93 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | KDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNKNRPED |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15181 | T246 | Sugiyama | PPA1 IOPPP PP | HWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDAL |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15365 | S111 | Sugiyama | PCBP1 | TAASRPPVTLRLVVPATQCGsLIGKGGCKIKEIREstGAQV |
| Q15393 | S1184 | Sugiyama | SF3B3 KIAA0017 SAP130 | RSyyFPVKNVIDGDLCEQFNsMEPNKQKNVSEELDRtPPEV |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15691 | S140 | Sugiyama | MAPRE1 | DGKDyDPVAARQGQEtAVAPsLVAPALNKPKKPLtsssAAP |
| Q15691 | T135 | Sugiyama | MAPRE1 | FDANyDGKDyDPVAARQGQEtAVAPsLVAPALNKPKKPLts |
| Q15797 | T322 | GPS6|SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | PSNNKNRFCLGLLsNVNRNstIENTRRHIGKGVHLYYVGGE |
| Q16643 | T161 | Sugiyama | DBN1 D0S117E | ssPVLHRLRLREDENAEPVGttyQKTDAAVEMKRINREQFW |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q2VIR3 | T41 | Sugiyama | EIF2S3B | ttLDVtKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAI |
| Q2VIR3 | T46 | Sugiyama | EIF2S3B | tKLTPLSHEVISRQAtINIGtIGHVAHGKSTVVKAISGVHT |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | T36 | Sugiyama | HSP90AB4P | LQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPNPR |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF7 | T60 | Sugiyama | HSP90AB3P HSP90BC | LQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q58FF8 | T60 | Sugiyama | HSP90AB2P HSP90BB | LWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQ |
| Q58FG1 | T28 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | SKLDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLG |
| Q58FG1 | T30 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | LDSGKEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTI |
| Q58FG1 | T34 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | KEPHISLIPNKQDRtLtIVDtGIGMTKADLINNLGTITKSE |
| Q5T0F9 | S209 | Sugiyama | CC2D1B KIAA1836 LGD1 | EAAKARRCERGLKTLESQLAsVRRGRKINEDEIPPPVALGK |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5VZF2 | S56 | Sugiyama | MBNL2 MBLL MBLL39 MLP1 | FAHPPKSCQVENGRVIACFDsLKGRCSRENCKYLHPPTHLK |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T929 | Sugiyama | POTEE A26C1A POTE2 | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | T779 | Sugiyama | SND1 TDRD11 | IHVFYIDYGNREVLPSTRLGtLsPAFsTRVLPAQATEYAFA |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N0Y7 | T96 | Sugiyama | PGAM4 PGAM3 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBJ7 | T42 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | LGNGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPF |
| Q8NHW5 | T122 | Sugiyama | RPLP0P6 | LLANKVPAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALG |
| Q8NHW5 | T128 | Sugiyama | RPLP0P6 | PAAARAGAIAPCEVtVPAQNtGLGPEKTSFFQALGItTKIS |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92888 | S409 | Sugiyama | ARHGEF1 | ELEPEEPPGWRELVPPDtLHsLPKSQVKRQEVISELLVTEA |
| Q92888 | T406 | Sugiyama | ARHGEF1 | SGLELEPEEPPGWRELVPPDtLHsLPKSQVKRQEVISELLV |
| Q96AY3 | T200 | Sugiyama | FKBP10 FKBP65 PSEC0056 | HYNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLG |
| Q96AY3 | T203 | Sugiyama | FKBP10 FKBP65 PSEC0056 | GTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCP |
| Q96AY3 | Y201 | Sugiyama | FKBP10 FKBP65 PSEC0056 | YNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGM |
| Q96G46 | T167 | Sugiyama | DUS3L | VGRYLETKPADLGPRCVLFEtFGRCPYGVtCRFAGAHLRPE |
| Q96G46 | T176 | Sugiyama | DUS3L | ADLGPRCVLFEtFGRCPYGVtCRFAGAHLRPEGQNLVQEEL |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q99460 | T830 | Sugiyama | PSMD1 | TFAYPAPLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKE |
| Q99460 | T836 | Sugiyama | PSMD1 | PLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKEEEKMEV |
| Q99575 | T134 | Sugiyama | POP1 KIAA0061 | EISAMLKAVTQKssNsLVFQtLPRHMRRRAMSHNVKRLPRR |
| Q99613 | S639 | Sugiyama | EIF3C EIF3S8 | CAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQERN |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BUF5 | T312 | Sugiyama | TUBB6 | QMFDARNMMAACDPRHGRYLtVAtVFRGPMSMKEVDEQMLA |
| Q9BUF5 | T315 | Sugiyama | TUBB6 | DARNMMAACDPRHGRYLtVAtVFRGPMSMKEVDEQMLAIQS |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9GZT8 | T149 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | AYDAAPQGVNNWLAKGLGACtSRPIHPSKAPNyPTEGNHRV |
| Q9H0A0 | S593 | Sugiyama | NAT10 ALP KIAA1709 | VLAVIQVCLEGEISRQSILNsLSRGKKASGDLIPWTVSEQF |
| Q9H173 | T123 | Sugiyama | SIL1 UNQ545/PRO836 | KLQYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAE |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NQB0 | S177 | SIGNOR|EPSD|PSP | TCF7L2 TCF4 | PLLDVQAGSLQSRQALKDARsPsPAHIVsNKVPVVQHPHHV |
| Q9NR56 | S56 | Sugiyama | MBNL1 EXP KIAA0428 MBNL | FAHPSKSCQVENGRVIACFDsLKGRCSRENCKyLHPPPHLK |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UHD1 | T204 | Sugiyama | CHORDC1 CHP1 | IFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTKKDAG |
| Q9UHD1 | T212 | Sugiyama | CHORDC1 CHP1 | WSCCRRKtsDFNtFLAQEGCtKGKHMWTKKDAGKKVVPCRH |
| Q9UHR6 | T316 | Sugiyama | ZNHIT2 C11orf5 | GEGPTNQKGyTLAALGDLAQtLGRARKQAVAREERDHLYRA |
| Q9UHR6 | Y305 | Sugiyama | ZNHIT2 C11orf5 | GAMHEVARILLGEGPTNQKGyTLAALGDLAQtLGRARKQAV |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UKE5 | S640 | EPSD | TNIK KIAA0551 | SGFQEALNVTSHRVEMPRQNsDPtSENPPLPTRIEKFDRss |
| Q9UKE5 | S680 | EPSD | TNIK KIAA0551 | sWLRQEEDIPPKVPQRttsIsPALARKNsPGNGSALGPRLG |
| Q9UKE5 | T181 | EPSD | TNIK KIAA0551 | LTENAEVKLVDFGVsAQLDRtVGRRNtFIGTPYWMAPEVIA |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ80 | T279 | Sugiyama | PA2G4 EBP1 | MKtSRAFFsEVERRFDAMPFtLRAFEDEKKARMGVVECAKH |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQ80 | T60 | Sugiyama | PA2G4 EBP1 | ssGVsVLsLCEKGDAMIMEEtGKIFKKEKEMKKGIAFPTSI |
| Q9Y230 | T194 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | LGTKMIESLTKDKVQAGDVItIDKAtGKISKLGRSFTRARD |
| Q9Y230 | T459 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | STQYMKEyQDAFLFNELKGEtMDTS________________ |
| Q9Y265 | S179 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | IGLKTAKGTKQLKLDPSIFEsLQKERVEAGDVIyIEANSGA |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y383 | T17 | Sugiyama | LUC7L2 CGI-59 CGI-74 | ____MSAQAQMRAMLDQLMGtsRDGDttRQRIKFSDDRVCK |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S461 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | VVYPILVEFTREVEEEPGIHsLKHNKRVLFSRMGPYPQRKV |
| Q9Y5L4 | T79 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | DNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERANM____ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic execution phase | R-HSA-75153 | 5.637436e-08 | 7.249 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.120000e-07 | 6.291 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.742544e-05 | 4.759 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.623751e-05 | 4.335 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.816239e-05 | 4.055 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.337678e-05 | 4.030 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.076576e-04 | 3.968 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.783608e-04 | 3.555 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.741968e-04 | 3.562 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.660000e-04 | 3.575 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.138093e-04 | 3.383 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.765066e-04 | 3.322 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.091181e-04 | 3.293 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.258476e-04 | 3.083 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.833370e-04 | 3.106 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.068662e-04 | 3.093 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.324060e-04 | 3.080 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.152236e-04 | 3.038 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.037575e-03 | 2.984 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.048075e-03 | 2.980 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.102103e-03 | 2.958 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.375972e-03 | 2.861 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.621575e-03 | 2.790 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.621173e-03 | 2.790 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.602704e-03 | 2.795 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.902924e-03 | 2.721 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.902924e-03 | 2.721 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.902924e-03 | 2.721 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.816895e-03 | 2.741 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.230181e-03 | 2.652 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.366695e-03 | 2.626 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.133009e-03 | 2.671 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.366695e-03 | 2.626 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.366695e-03 | 2.626 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.144818e-03 | 2.669 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.397474e-03 | 2.620 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.589019e-03 | 2.587 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.843232e-03 | 2.546 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.843232e-03 | 2.546 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.946410e-03 | 2.531 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.946410e-03 | 2.531 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.377038e-03 | 2.471 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.377038e-03 | 2.471 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.122803e-03 | 2.385 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.122803e-03 | 2.385 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.981694e-03 | 2.400 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.122803e-03 | 2.385 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.334083e-03 | 2.363 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.400913e-03 | 2.356 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.950953e-03 | 2.305 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.950953e-03 | 2.305 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.088821e-03 | 2.293 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.499927e-03 | 2.260 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.203395e-03 | 2.207 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.203395e-03 | 2.207 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.203395e-03 | 2.207 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.203395e-03 | 2.207 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.243672e-03 | 2.205 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.263046e-03 | 2.203 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.597212e-03 | 2.181 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.222948e-03 | 2.141 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.599924e-03 | 2.119 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.272048e-03 | 2.082 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.680878e-03 | 2.061 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.828105e-03 | 2.008 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.828105e-03 | 2.008 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.318319e-03 | 2.031 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.014105e-02 | 1.994 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.014105e-02 | 1.994 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.061571e-02 | 1.974 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.119207e-02 | 1.951 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.142141e-02 | 1.942 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.184892e-02 | 1.926 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.239779e-02 | 1.907 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.285758e-02 | 1.891 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.408921e-02 | 1.851 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.408921e-02 | 1.851 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.531672e-02 | 1.815 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.574313e-02 | 1.803 | 1 | 1 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.574313e-02 | 1.803 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.466096e-02 | 1.834 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.640327e-02 | 1.785 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.750413e-02 | 1.757 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.803912e-02 | 1.744 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.803912e-02 | 1.744 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.859011e-02 | 1.731 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.983767e-02 | 1.703 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.986333e-02 | 1.702 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.030806e-02 | 1.692 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.222084e-02 | 1.653 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.310237e-02 | 1.636 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.323562e-02 | 1.634 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.391681e-02 | 1.621 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.415405e-02 | 1.617 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.620972e-02 | 1.582 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.764977e-02 | 1.558 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.828521e-02 | 1.548 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.897918e-02 | 1.538 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.055570e-02 | 1.515 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.138401e-02 | 1.503 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.418238e-02 | 1.466 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.172916e-02 | 1.499 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.463764e-02 | 1.460 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.280824e-02 | 1.484 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.299891e-02 | 1.482 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.510580e-02 | 1.455 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.510580e-02 | 1.455 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.525603e-02 | 1.453 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.559500e-02 | 1.449 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.585728e-02 | 1.445 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.015095e-02 | 1.396 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.039638e-02 | 1.394 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.039638e-02 | 1.394 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.719387e-02 | 1.430 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.923551e-02 | 1.406 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.697047e-02 | 1.432 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.890062e-02 | 1.410 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.264366e-02 | 1.370 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.570138e-02 | 1.340 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.639876e-02 | 1.333 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.328964e-02 | 1.364 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.570138e-02 | 1.340 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.570138e-02 | 1.340 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.582062e-02 | 1.339 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.708527e-02 | 1.327 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.812546e-02 | 1.318 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.324682e-02 | 1.364 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.602592e-02 | 1.337 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.381336e-02 | 1.358 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.812546e-02 | 1.318 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.920517e-02 | 1.308 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.920517e-02 | 1.308 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.955872e-02 | 1.305 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.984090e-02 | 1.302 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.132082e-02 | 1.290 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.998983e-02 | 1.222 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.749661e-02 | 1.240 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.358760e-02 | 1.271 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.998983e-02 | 1.222 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.486782e-02 | 1.261 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.703018e-02 | 1.244 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.266867e-02 | 1.278 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.784156e-02 | 1.238 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.998983e-02 | 1.222 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.571475e-02 | 1.254 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.956941e-02 | 1.225 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.575773e-02 | 1.254 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.039451e-02 | 1.219 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.248914e-02 | 1.204 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.388036e-02 | 1.195 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.388036e-02 | 1.195 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.439575e-02 | 1.191 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.463888e-02 | 1.190 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.466797e-02 | 1.189 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.476387e-02 | 1.189 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.584197e-02 | 1.120 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 7.584197e-02 | 1.120 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.584197e-02 | 1.120 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.077477e-02 | 1.150 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.025967e-02 | 1.153 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.025967e-02 | 1.153 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.548305e-02 | 1.122 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.548305e-02 | 1.122 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.814842e-02 | 1.167 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.173560e-02 | 1.144 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.542928e-02 | 1.122 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.584197e-02 | 1.120 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.057576e-02 | 1.151 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.305533e-02 | 1.136 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.218560e-02 | 1.142 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.077477e-02 | 1.150 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.611703e-02 | 1.119 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.740824e-02 | 1.111 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.837683e-02 | 1.106 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.008511e-02 | 1.096 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.115811e-01 | 0.952 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.115811e-01 | 0.952 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.115811e-01 | 0.952 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.115811e-01 | 0.952 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.115811e-01 | 0.952 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.115811e-01 | 0.952 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.459403e-01 | 0.836 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.459403e-01 | 0.836 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.459403e-01 | 0.836 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.459403e-01 | 0.836 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.459403e-01 | 0.836 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.789726e-01 | 0.747 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.789726e-01 | 0.747 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.107293e-01 | 0.676 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.107293e-01 | 0.676 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.107293e-01 | 0.676 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.107293e-01 | 0.676 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.107293e-01 | 0.676 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.107293e-01 | 0.676 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.107293e-01 | 0.676 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.107293e-01 | 0.676 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.399994e-02 | 1.027 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.399994e-02 | 1.027 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.063236e-01 | 0.973 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.063236e-01 | 0.973 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.412596e-01 | 0.618 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.412596e-01 | 0.618 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.412596e-01 | 0.618 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.190496e-01 | 0.924 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.190496e-01 | 0.924 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.190496e-01 | 0.924 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.321286e-01 | 0.879 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.706106e-01 | 0.568 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.706106e-01 | 0.568 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.706106e-01 | 0.568 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.455145e-01 | 0.837 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.486011e-02 | 1.071 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.242701e-02 | 1.034 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.242701e-02 | 1.034 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.591639e-01 | 0.798 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.988280e-01 | 0.525 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.988280e-01 | 0.525 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.002616e-01 | 0.999 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.730366e-01 | 0.762 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.730366e-01 | 0.762 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.730366e-01 | 0.762 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.730366e-01 | 0.762 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.259554e-01 | 0.487 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.259554e-01 | 0.487 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.259554e-01 | 0.487 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.259554e-01 | 0.487 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.430240e-01 | 0.845 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.520348e-01 | 0.453 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.520348e-01 | 0.453 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.520348e-01 | 0.453 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.106844e-01 | 0.956 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.300460e-01 | 0.638 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.171569e-01 | 0.931 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.128150e-02 | 1.040 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.711028e-01 | 0.767 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.771068e-01 | 0.424 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.771068e-01 | 0.424 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.807908e-01 | 0.743 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.807908e-01 | 0.743 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.714501e-02 | 1.060 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.005857e-01 | 0.698 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.735457e-01 | 0.563 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.012101e-01 | 0.397 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.042219e-01 | 0.982 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.880498e-01 | 0.541 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.880498e-01 | 0.541 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.133674e-01 | 0.946 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.311474e-01 | 0.636 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.025202e-01 | 0.519 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.025202e-01 | 0.519 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.243821e-01 | 0.372 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.169378e-01 | 0.499 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.519682e-01 | 0.599 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.312850e-01 | 0.480 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.312850e-01 | 0.480 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.466587e-01 | 0.350 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.466587e-01 | 0.350 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.466587e-01 | 0.350 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.836540e-01 | 0.547 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.680746e-01 | 0.330 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.680746e-01 | 0.330 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.680746e-01 | 0.330 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.680746e-01 | 0.330 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.680746e-01 | 0.330 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.680746e-01 | 0.330 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.680746e-01 | 0.330 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.737505e-01 | 0.427 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.737505e-01 | 0.427 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.730128e-01 | 0.564 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.730128e-01 | 0.564 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.014483e-01 | 0.396 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.079167e-01 | 0.512 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.079167e-01 | 0.512 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.343811e-01 | 0.476 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.418624e-01 | 0.355 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.786350e-01 | 0.422 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.215678e-01 | 0.375 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.319159e-01 | 0.365 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.524026e-01 | 0.344 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.294224e-01 | 0.367 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.597055e-01 | 0.444 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.735457e-01 | 0.563 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.735457e-01 | 0.563 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.807246e-01 | 0.318 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.156311e-01 | 0.666 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.156311e-01 | 0.666 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.150798e-01 | 0.382 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.735457e-01 | 0.563 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.285539e-01 | 0.368 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.383272e-01 | 0.471 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.597055e-01 | 0.444 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.171955e-01 | 0.663 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.786350e-01 | 0.422 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.820066e-01 | 0.740 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.140846e-01 | 0.383 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.519682e-01 | 0.599 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.285539e-01 | 0.368 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.300460e-01 | 0.638 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.625315e-01 | 0.335 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.399994e-02 | 1.027 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.486011e-02 | 1.071 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.666717e-01 | 0.778 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.339376e-01 | 0.873 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.340345e-01 | 0.873 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.208597e-01 | 0.656 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.399677e-01 | 0.357 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.742808e-01 | 0.759 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.418624e-01 | 0.355 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.167195e-01 | 0.499 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.107293e-01 | 0.676 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.455145e-01 | 0.837 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.013040e-01 | 0.696 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.522070e-01 | 0.818 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.936226e-01 | 0.532 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.571940e-01 | 0.340 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.445205e-01 | 0.612 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.278088e-01 | 0.642 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.807246e-01 | 0.318 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.399597e-01 | 0.357 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.680746e-01 | 0.330 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.737505e-01 | 0.427 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.418624e-01 | 0.355 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.764851e-01 | 0.753 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.225854e-01 | 0.374 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.063913e-01 | 0.391 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.107293e-01 | 0.676 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.412596e-01 | 0.618 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.412596e-01 | 0.618 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.730366e-01 | 0.762 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.730366e-01 | 0.762 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.520348e-01 | 0.453 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.838267e-01 | 0.736 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.680746e-01 | 0.330 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.263369e-01 | 0.486 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.226236e-01 | 0.911 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.821561e-01 | 0.550 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.821561e-01 | 0.550 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.821561e-01 | 0.550 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.319159e-01 | 0.365 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.048017e-01 | 0.516 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.013040e-01 | 0.696 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.139596e-01 | 0.670 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.213154e-02 | 1.085 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.874663e-01 | 0.412 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.412596e-01 | 0.618 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.706106e-01 | 0.568 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.730366e-01 | 0.762 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.730366e-01 | 0.762 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.259554e-01 | 0.487 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.771068e-01 | 0.424 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.597055e-01 | 0.444 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.418624e-01 | 0.355 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.549979e-01 | 0.342 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.340778e-01 | 0.873 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.171569e-01 | 0.931 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.171569e-01 | 0.931 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.466587e-01 | 0.350 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.089638e-02 | 1.092 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.170191e-01 | 0.932 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.771068e-01 | 0.424 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.166859e-01 | 0.933 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.365720e-01 | 0.473 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.399677e-01 | 0.357 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.263369e-01 | 0.486 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.649630e-02 | 1.063 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.014483e-01 | 0.396 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.115811e-01 | 0.952 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.115811e-01 | 0.952 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.115811e-01 | 0.952 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.063236e-01 | 0.973 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.412596e-01 | 0.618 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.412596e-01 | 0.618 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.190496e-01 | 0.924 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.706106e-01 | 0.568 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.706106e-01 | 0.568 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.706106e-01 | 0.568 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.455145e-01 | 0.837 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.455145e-01 | 0.837 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.988280e-01 | 0.525 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.259554e-01 | 0.487 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.252509e-01 | 0.902 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.520348e-01 | 0.453 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.652273e-02 | 1.063 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.590284e-01 | 0.587 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.012101e-01 | 0.397 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.012101e-01 | 0.397 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.012101e-01 | 0.397 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.012101e-01 | 0.397 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.012101e-01 | 0.397 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.169378e-01 | 0.499 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.519682e-01 | 0.599 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.207981e-01 | 0.918 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.312850e-01 | 0.480 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.466587e-01 | 0.350 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.466587e-01 | 0.350 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.466587e-01 | 0.350 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 1.340778e-01 | 0.873 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.680746e-01 | 0.330 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.680746e-01 | 0.330 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.680746e-01 | 0.330 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.876684e-01 | 0.412 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.014483e-01 | 0.396 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.477032e-01 | 0.459 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.285539e-01 | 0.368 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.369603e-01 | 0.472 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.561050e-01 | 0.592 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.201992e-01 | 0.657 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.156472e-01 | 0.501 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.518271e-01 | 0.819 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.951599e-01 | 0.530 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.715700e-01 | 0.430 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.680746e-01 | 0.330 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.460452e-01 | 0.836 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.225854e-01 | 0.374 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.213154e-02 | 1.085 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.412596e-01 | 0.618 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.520348e-01 | 0.453 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.679539e-01 | 0.330 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.492181e-01 | 0.826 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.649630e-02 | 1.063 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.227914e-02 | 1.035 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.285539e-01 | 0.368 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.726980e-01 | 0.564 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.049643e-01 | 0.516 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.591639e-01 | 0.798 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.430240e-01 | 0.845 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.771068e-01 | 0.424 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.012101e-01 | 0.397 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.106687e-01 | 0.676 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.680746e-01 | 0.330 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.874663e-01 | 0.412 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.242701e-02 | 1.034 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.208597e-01 | 0.656 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.772210e-01 | 0.423 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.870950e-01 | 0.728 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.252509e-01 | 0.902 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.221808e-01 | 0.653 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.455459e-01 | 0.461 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.614150e-01 | 0.336 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.036473e-01 | 0.518 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.036473e-01 | 0.518 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.680746e-01 | 0.330 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.545809e-01 | 0.342 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.480475e-01 | 0.830 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.156472e-01 | 0.501 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.115811e-01 | 0.952 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.789726e-01 | 0.747 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.789726e-01 | 0.747 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.213154e-02 | 1.085 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.213154e-02 | 1.085 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.107293e-01 | 0.676 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.412596e-01 | 0.618 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.706106e-01 | 0.568 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.259554e-01 | 0.487 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.259554e-01 | 0.487 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.520348e-01 | 0.453 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.520348e-01 | 0.453 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.520348e-01 | 0.453 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.106844e-01 | 0.956 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.106844e-01 | 0.956 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.300460e-01 | 0.638 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.771068e-01 | 0.424 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.771068e-01 | 0.424 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.807908e-01 | 0.743 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.012101e-01 | 0.397 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.208597e-01 | 0.656 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.876684e-01 | 0.412 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.014483e-01 | 0.396 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.686595e-01 | 0.571 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.369272e-01 | 0.472 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.986854e-01 | 0.399 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.972475e-01 | 0.705 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.321605e-01 | 0.634 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.346159e-01 | 0.630 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.461945e-01 | 0.835 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.684435e-01 | 0.774 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.522399e-01 | 0.598 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.004304e-01 | 0.698 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.308064e-01 | 0.637 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.308064e-01 | 0.637 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.698087e-01 | 0.432 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.792780e-01 | 0.421 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.706106e-01 | 0.568 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.635974e-01 | 0.439 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.055736e-01 | 0.687 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.597055e-01 | 0.444 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.370249e-01 | 0.472 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.370249e-01 | 0.472 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.349744e-01 | 0.870 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.399677e-01 | 0.357 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.789726e-01 | 0.747 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.063236e-01 | 0.973 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.242701e-02 | 1.034 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.988280e-01 | 0.525 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.988280e-01 | 0.525 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.445205e-01 | 0.612 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.208597e-01 | 0.656 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.473091e-01 | 0.607 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.263369e-01 | 0.486 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.991393e-01 | 0.524 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.549979e-01 | 0.342 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.838267e-01 | 0.736 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.383672e-01 | 0.859 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.588532e-01 | 0.799 | 1 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.684435e-01 | 0.774 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.730366e-01 | 0.762 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.836540e-01 | 0.547 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.466587e-01 | 0.350 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.168610e-01 | 0.932 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.459403e-01 | 0.836 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.789726e-01 | 0.747 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.107293e-01 | 0.676 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.412596e-01 | 0.618 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.412596e-01 | 0.618 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.706106e-01 | 0.568 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.870950e-01 | 0.728 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.259554e-01 | 0.487 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.259554e-01 | 0.487 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.259554e-01 | 0.487 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.259554e-01 | 0.487 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.771068e-01 | 0.424 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.012101e-01 | 0.397 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.880498e-01 | 0.541 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.398078e-01 | 0.854 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.025202e-01 | 0.519 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.243821e-01 | 0.372 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.466587e-01 | 0.350 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.836540e-01 | 0.547 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.836540e-01 | 0.547 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.942969e-01 | 0.531 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.680746e-01 | 0.330 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.680746e-01 | 0.330 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.680746e-01 | 0.330 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 4.150798e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.379203e-01 | 0.860 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.597055e-01 | 0.444 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.820123e-01 | 0.740 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.972475e-01 | 0.705 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.285539e-01 | 0.368 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.522686e-01 | 0.345 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.166859e-01 | 0.933 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.166859e-01 | 0.933 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.447549e-01 | 0.462 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.480446e-01 | 0.830 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.679539e-01 | 0.330 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.528475e-01 | 0.816 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.167195e-01 | 0.499 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.040817e-01 | 0.690 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.727607e-01 | 0.763 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.836540e-01 | 0.547 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.836540e-01 | 0.547 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.876684e-01 | 0.412 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.014483e-01 | 0.396 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.807246e-01 | 0.318 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.853361e-01 | 0.732 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.063236e-01 | 0.973 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.430240e-01 | 0.845 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.930989e-01 | 0.533 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.706106e-01 | 0.568 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.706106e-01 | 0.568 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.591639e-01 | 0.798 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.988280e-01 | 0.525 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.259554e-01 | 0.487 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.013040e-01 | 0.696 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.771068e-01 | 0.424 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.771068e-01 | 0.424 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.771068e-01 | 0.424 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.025202e-01 | 0.519 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.243821e-01 | 0.372 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.243821e-01 | 0.372 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.624798e-01 | 0.581 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.098210e-01 | 0.959 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.049643e-01 | 0.516 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.583640e-01 | 0.446 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.308064e-01 | 0.637 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.549979e-01 | 0.342 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.030767e-01 | 0.518 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.876309e-01 | 0.727 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.116193e-01 | 0.952 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.285539e-01 | 0.368 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.735457e-01 | 0.563 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.028197e-01 | 0.693 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.326550e-01 | 0.633 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.358348e-01 | 0.361 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.300460e-01 | 0.638 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.486011e-02 | 1.071 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.179798e-01 | 0.662 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.433145e-01 | 0.844 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.014483e-01 | 0.396 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.150798e-01 | 0.382 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.446030e-01 | 0.840 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.680746e-01 | 0.330 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.680746e-01 | 0.330 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.679539e-01 | 0.330 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.591852e-01 | 0.798 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.524026e-01 | 0.344 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.181575e-01 | 0.379 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.062205e-01 | 0.514 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.369603e-01 | 0.472 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.619258e-01 | 0.582 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.549979e-01 | 0.342 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.412596e-01 | 0.618 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.730366e-01 | 0.762 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.340345e-01 | 0.873 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.520348e-01 | 0.453 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.771068e-01 | 0.424 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.012101e-01 | 0.397 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.549979e-01 | 0.342 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.678332e-01 | 0.775 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.735457e-01 | 0.563 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.263369e-01 | 0.486 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.399677e-01 | 0.357 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.430240e-01 | 0.845 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.880498e-01 | 0.541 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.625315e-01 | 0.335 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.597055e-01 | 0.444 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.005857e-01 | 0.698 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.083520e-01 | 0.965 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.735457e-01 | 0.563 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.680746e-01 | 0.330 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.737505e-01 | 0.427 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.083520e-01 | 0.965 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.399994e-02 | 1.027 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.796038e-01 | 0.421 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.242701e-02 | 1.034 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.687528e-01 | 0.433 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.466587e-01 | 0.350 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.370617e-01 | 0.359 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.455459e-01 | 0.461 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.811487e-01 | 0.318 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.825386e-01 | 0.316 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.854927e-01 | 0.314 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.886628e-01 | 0.311 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 4.886628e-01 | 0.311 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.886628e-01 | 0.311 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 4.886628e-01 | 0.311 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.886628e-01 | 0.311 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.886628e-01 | 0.311 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.886628e-01 | 0.311 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.886628e-01 | 0.311 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.886628e-01 | 0.311 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.886628e-01 | 0.311 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.910772e-01 | 0.309 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.910772e-01 | 0.309 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.924086e-01 | 0.308 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.933050e-01 | 0.307 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.933050e-01 | 0.307 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.933050e-01 | 0.307 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.971487e-01 | 0.304 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.997136e-01 | 0.301 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.021848e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.021848e-01 | 0.299 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.021848e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.021848e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.021848e-01 | 0.299 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.021848e-01 | 0.299 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.044983e-01 | 0.297 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.056907e-01 | 0.296 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.056907e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.056907e-01 | 0.296 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.056907e-01 | 0.296 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.056907e-01 | 0.296 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.056907e-01 | 0.296 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.084554e-01 | 0.294 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.084554e-01 | 0.294 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.084554e-01 | 0.294 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.084554e-01 | 0.294 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.084554e-01 | 0.294 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.084554e-01 | 0.294 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.118637e-01 | 0.291 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.118637e-01 | 0.291 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.118637e-01 | 0.291 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.149758e-01 | 0.288 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.178778e-01 | 0.286 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.178778e-01 | 0.286 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.180621e-01 | 0.286 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.180621e-01 | 0.286 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.206266e-01 | 0.283 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.214421e-01 | 0.283 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.240529e-01 | 0.281 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.241247e-01 | 0.281 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.274439e-01 | 0.278 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.274830e-01 | 0.278 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.274830e-01 | 0.278 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.274830e-01 | 0.278 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 5.274830e-01 | 0.278 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.274830e-01 | 0.278 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.274830e-01 | 0.278 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.274830e-01 | 0.278 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.298633e-01 | 0.276 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.298633e-01 | 0.276 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.298633e-01 | 0.276 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.298633e-01 | 0.276 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.321366e-01 | 0.274 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.321366e-01 | 0.274 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.402864e-01 | 0.267 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.416445e-01 | 0.266 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.416445e-01 | 0.266 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.416445e-01 | 0.266 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.457752e-01 | 0.263 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.457752e-01 | 0.263 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.457752e-01 | 0.263 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.457752e-01 | 0.263 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.457752e-01 | 0.263 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.457752e-01 | 0.263 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.457752e-01 | 0.263 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.457752e-01 | 0.263 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.457752e-01 | 0.263 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.457752e-01 | 0.263 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.480970e-01 | 0.261 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.532192e-01 | 0.257 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.532192e-01 | 0.257 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.559698e-01 | 0.255 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.559698e-01 | 0.255 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.604501e-01 | 0.251 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.616216e-01 | 0.251 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.633603e-01 | 0.249 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.633603e-01 | 0.249 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.633603e-01 | 0.249 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.633603e-01 | 0.249 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.637688e-01 | 0.249 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.645857e-01 | 0.248 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.645857e-01 | 0.248 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.645857e-01 | 0.248 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.645857e-01 | 0.248 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.645857e-01 | 0.248 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.648395e-01 | 0.248 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.667568e-01 | 0.247 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.677342e-01 | 0.246 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.714923e-01 | 0.243 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.714923e-01 | 0.243 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.714923e-01 | 0.243 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.745080e-01 | 0.241 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.753807e-01 | 0.240 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.753807e-01 | 0.240 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.757429e-01 | 0.240 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.757429e-01 | 0.240 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.772751e-01 | 0.239 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.802657e-01 | 0.236 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.802657e-01 | 0.236 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 5.802657e-01 | 0.236 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.802657e-01 | 0.236 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.802657e-01 | 0.236 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.802657e-01 | 0.236 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.866665e-01 | 0.232 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.866899e-01 | 0.232 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.866899e-01 | 0.232 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.866899e-01 | 0.232 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.866899e-01 | 0.232 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.866899e-01 | 0.232 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.866899e-01 | 0.232 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.901990e-01 | 0.229 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.915359e-01 | 0.228 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.941516e-01 | 0.226 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.941950e-01 | 0.226 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.950840e-01 | 0.225 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.955853e-01 | 0.225 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.961821e-01 | 0.225 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.965175e-01 | 0.224 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.965175e-01 | 0.224 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.965175e-01 | 0.224 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.965175e-01 | 0.224 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.965175e-01 | 0.224 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.965175e-01 | 0.224 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.965175e-01 | 0.224 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.965175e-01 | 0.224 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 5.965175e-01 | 0.224 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.965175e-01 | 0.224 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.965175e-01 | 0.224 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.965175e-01 | 0.224 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.974262e-01 | 0.224 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.016023e-01 | 0.221 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.016023e-01 | 0.221 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.022000e-01 | 0.220 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.022000e-01 | 0.220 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.027212e-01 | 0.220 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.027212e-01 | 0.220 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.079518e-01 | 0.216 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.121410e-01 | 0.213 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.121410e-01 | 0.213 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.121410e-01 | 0.213 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.121410e-01 | 0.213 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.121410e-01 | 0.213 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.121410e-01 | 0.213 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.121410e-01 | 0.213 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.121410e-01 | 0.213 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.121410e-01 | 0.213 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.121410e-01 | 0.213 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.121410e-01 | 0.213 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.152435e-01 | 0.211 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.161697e-01 | 0.210 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.161697e-01 | 0.210 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.182669e-01 | 0.209 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.182669e-01 | 0.209 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.182669e-01 | 0.209 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.182669e-01 | 0.209 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.194987e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.216705e-01 | 0.206 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.216705e-01 | 0.206 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.271605e-01 | 0.203 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.271605e-01 | 0.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.271605e-01 | 0.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.271605e-01 | 0.203 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.271605e-01 | 0.203 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.271605e-01 | 0.203 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.271605e-01 | 0.203 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.271605e-01 | 0.203 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.271605e-01 | 0.203 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.271605e-01 | 0.203 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.271605e-01 | 0.203 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.277049e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.277049e-01 | 0.202 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.283719e-01 | 0.202 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.283719e-01 | 0.202 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.283719e-01 | 0.202 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.304010e-01 | 0.200 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.357885e-01 | 0.197 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.382678e-01 | 0.195 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.415992e-01 | 0.193 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.415992e-01 | 0.193 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.415992e-01 | 0.193 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.415992e-01 | 0.193 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 6.415992e-01 | 0.193 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.415992e-01 | 0.193 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.415992e-01 | 0.193 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.433836e-01 | 0.192 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.442899e-01 | 0.191 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.467290e-01 | 0.189 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.467290e-01 | 0.189 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.467290e-01 | 0.189 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.479554e-01 | 0.188 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.479554e-01 | 0.188 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.485406e-01 | 0.188 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.500476e-01 | 0.187 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.554796e-01 | 0.183 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.554796e-01 | 0.183 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.554796e-01 | 0.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.554796e-01 | 0.183 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.554796e-01 | 0.183 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.574362e-01 | 0.182 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.574362e-01 | 0.182 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.578312e-01 | 0.182 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.588599e-01 | 0.181 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.588599e-01 | 0.181 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.611170e-01 | 0.180 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.611170e-01 | 0.180 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.644702e-01 | 0.178 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.665692e-01 | 0.176 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.667116e-01 | 0.176 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.667116e-01 | 0.176 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.688233e-01 | 0.175 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.688233e-01 | 0.175 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.688233e-01 | 0.175 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.688233e-01 | 0.175 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.688233e-01 | 0.175 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.688233e-01 | 0.175 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.710210e-01 | 0.173 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.710210e-01 | 0.173 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.710210e-01 | 0.173 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.743530e-01 | 0.171 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.743530e-01 | 0.171 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.757832e-01 | 0.170 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.757832e-01 | 0.170 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.773065e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.774833e-01 | 0.169 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.816509e-01 | 0.166 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.816509e-01 | 0.166 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.816509e-01 | 0.166 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.816942e-01 | 0.166 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.827532e-01 | 0.166 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.834312e-01 | 0.165 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.846530e-01 | 0.165 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.846530e-01 | 0.165 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.878190e-01 | 0.163 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.878190e-01 | 0.163 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.878190e-01 | 0.163 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.879944e-01 | 0.162 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.901415e-01 | 0.161 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.929902e-01 | 0.159 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.929902e-01 | 0.159 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.933229e-01 | 0.159 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.933229e-01 | 0.159 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.933229e-01 | 0.159 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 6.936142e-01 | 0.159 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.939824e-01 | 0.159 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.939824e-01 | 0.159 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.939824e-01 | 0.159 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.939824e-01 | 0.159 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.962071e-01 | 0.157 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.963370e-01 | 0.157 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.963370e-01 | 0.157 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.963370e-01 | 0.157 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.991644e-01 | 0.155 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.994504e-01 | 0.155 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.031615e-01 | 0.153 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.058370e-01 | 0.151 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.058370e-01 | 0.151 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.058370e-01 | 0.151 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.058370e-01 | 0.151 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.058370e-01 | 0.151 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.058370e-01 | 0.151 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.084611e-01 | 0.150 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.084611e-01 | 0.150 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.098256e-01 | 0.149 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.098256e-01 | 0.149 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.100720e-01 | 0.149 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.100720e-01 | 0.149 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.165523e-01 | 0.145 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.172330e-01 | 0.144 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.172330e-01 | 0.144 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.172330e-01 | 0.144 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.172330e-01 | 0.144 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.172330e-01 | 0.144 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.172330e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.172330e-01 | 0.144 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.181559e-01 | 0.144 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.181559e-01 | 0.144 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.202293e-01 | 0.143 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.202293e-01 | 0.143 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.202293e-01 | 0.143 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.229268e-01 | 0.141 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.260494e-01 | 0.139 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.260494e-01 | 0.139 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.260494e-01 | 0.139 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.281882e-01 | 0.138 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.281882e-01 | 0.138 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.281882e-01 | 0.138 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.281882e-01 | 0.138 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.281882e-01 | 0.138 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.281882e-01 | 0.138 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.281882e-01 | 0.138 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.281882e-01 | 0.138 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.309990e-01 | 0.136 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.369488e-01 | 0.133 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.373469e-01 | 0.132 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.387197e-01 | 0.132 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.387197e-01 | 0.132 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.387197e-01 | 0.132 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.387197e-01 | 0.132 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.387197e-01 | 0.132 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.387197e-01 | 0.132 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.412756e-01 | 0.130 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.412756e-01 | 0.130 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.412756e-01 | 0.130 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.412756e-01 | 0.130 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.412756e-01 | 0.130 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.422532e-01 | 0.129 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.432813e-01 | 0.129 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.477024e-01 | 0.126 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.483811e-01 | 0.126 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.486137e-01 | 0.126 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.486137e-01 | 0.126 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.488437e-01 | 0.126 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.488437e-01 | 0.126 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.488437e-01 | 0.126 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.488437e-01 | 0.126 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.488437e-01 | 0.126 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.488437e-01 | 0.126 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.520246e-01 | 0.124 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.534159e-01 | 0.123 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.534159e-01 | 0.123 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.556098e-01 | 0.122 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.557723e-01 | 0.122 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.557723e-01 | 0.122 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.557723e-01 | 0.122 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.557723e-01 | 0.122 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.557723e-01 | 0.122 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.585760e-01 | 0.120 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.585760e-01 | 0.120 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.585760e-01 | 0.120 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.585760e-01 | 0.120 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.585760e-01 | 0.120 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.585760e-01 | 0.120 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.586417e-01 | 0.120 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.598704e-01 | 0.119 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.627543e-01 | 0.118 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.627543e-01 | 0.118 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.627543e-01 | 0.118 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.627543e-01 | 0.118 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.627543e-01 | 0.118 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.636600e-01 | 0.117 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.679317e-01 | 0.115 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.688356e-01 | 0.114 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.695626e-01 | 0.114 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.717327e-01 | 0.113 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.717327e-01 | 0.113 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.717960e-01 | 0.112 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.769255e-01 | 0.110 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.769255e-01 | 0.110 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 7.769255e-01 | 0.110 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.769255e-01 | 0.110 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.769255e-01 | 0.110 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.769662e-01 | 0.110 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.826699e-01 | 0.106 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.855712e-01 | 0.105 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.855712e-01 | 0.105 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.855712e-01 | 0.105 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.855712e-01 | 0.105 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.855712e-01 | 0.105 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.855712e-01 | 0.105 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.855712e-01 | 0.105 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.855712e-01 | 0.105 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.871802e-01 | 0.104 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.914209e-01 | 0.102 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.928443e-01 | 0.101 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.938824e-01 | 0.100 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.938824e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.938824e-01 | 0.100 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.938824e-01 | 0.100 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.938824e-01 | 0.100 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.938824e-01 | 0.100 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.938824e-01 | 0.100 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.951184e-01 | 0.100 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.005979e-01 | 0.097 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.011032e-01 | 0.096 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.018718e-01 | 0.096 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.018718e-01 | 0.096 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.018718e-01 | 0.096 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.018718e-01 | 0.096 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.018718e-01 | 0.096 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.018718e-01 | 0.096 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.018718e-01 | 0.096 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.018718e-01 | 0.096 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.034069e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.034069e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.034069e-01 | 0.095 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.037478e-01 | 0.095 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.056448e-01 | 0.094 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.062636e-01 | 0.094 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.095521e-01 | 0.092 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.095521e-01 | 0.092 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.095521e-01 | 0.092 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.126091e-01 | 0.090 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.126091e-01 | 0.090 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.126091e-01 | 0.090 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.131116e-01 | 0.090 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.169351e-01 | 0.088 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.169351e-01 | 0.088 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.169351e-01 | 0.088 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.169351e-01 | 0.088 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.181363e-01 | 0.087 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.224078e-01 | 0.085 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.224078e-01 | 0.085 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.235172e-01 | 0.084 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.235172e-01 | 0.084 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.240324e-01 | 0.084 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.240324e-01 | 0.084 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.240324e-01 | 0.084 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.240324e-01 | 0.084 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.240324e-01 | 0.084 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.240324e-01 | 0.084 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.266665e-01 | 0.083 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.287547e-01 | 0.082 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.308549e-01 | 0.080 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.308549e-01 | 0.080 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.308549e-01 | 0.080 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.308549e-01 | 0.080 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.313069e-01 | 0.080 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.316742e-01 | 0.080 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.373307e-01 | 0.077 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.374132e-01 | 0.077 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.374132e-01 | 0.077 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.374132e-01 | 0.077 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.381605e-01 | 0.077 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.436371e-01 | 0.074 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.437177e-01 | 0.074 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.437177e-01 | 0.074 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.483311e-01 | 0.071 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.497781e-01 | 0.071 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.497781e-01 | 0.071 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.497781e-01 | 0.071 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.497781e-01 | 0.071 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.497781e-01 | 0.071 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.518945e-01 | 0.070 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.528966e-01 | 0.069 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.528966e-01 | 0.069 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.546141e-01 | 0.068 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.556038e-01 | 0.068 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.556038e-01 | 0.068 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.556038e-01 | 0.068 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.556038e-01 | 0.068 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.557392e-01 | 0.068 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.573366e-01 | 0.067 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.573366e-01 | 0.067 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.612040e-01 | 0.065 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.612040e-01 | 0.065 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.612040e-01 | 0.065 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.612040e-01 | 0.065 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.658512e-01 | 0.063 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.659856e-01 | 0.062 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.667544e-01 | 0.062 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.688951e-01 | 0.061 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.699315e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.702581e-01 | 0.060 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.717620e-01 | 0.060 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.717620e-01 | 0.060 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.717620e-01 | 0.060 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.717620e-01 | 0.060 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.736803e-01 | 0.059 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.767364e-01 | 0.057 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.767364e-01 | 0.057 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.767364e-01 | 0.057 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.767364e-01 | 0.057 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.767364e-01 | 0.057 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.767364e-01 | 0.057 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 8.767364e-01 | 0.057 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.777518e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.802857e-01 | 0.055 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.805998e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.815181e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.815181e-01 | 0.055 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.815181e-01 | 0.055 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.836871e-01 | 0.054 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.861146e-01 | 0.053 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.861146e-01 | 0.053 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 8.861146e-01 | 0.053 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.871069e-01 | 0.052 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.886719e-01 | 0.051 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.896185e-01 | 0.051 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.898350e-01 | 0.051 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.905331e-01 | 0.050 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.905331e-01 | 0.050 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.905331e-01 | 0.050 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.925053e-01 | 0.049 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.947804e-01 | 0.048 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.988631e-01 | 0.046 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.010482e-01 | 0.045 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.018277e-01 | 0.045 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.026273e-01 | 0.044 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.027877e-01 | 0.044 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.027877e-01 | 0.044 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.065602e-01 | 0.043 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.065602e-01 | 0.043 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.065602e-01 | 0.043 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.101865e-01 | 0.041 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.101865e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.107272e-01 | 0.041 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.107272e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.136723e-01 | 0.039 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.136723e-01 | 0.039 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.138299e-01 | 0.039 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.162343e-01 | 0.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.170230e-01 | 0.038 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.170230e-01 | 0.038 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.202439e-01 | 0.036 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.202439e-01 | 0.036 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.202439e-01 | 0.036 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.233399e-01 | 0.035 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.238999e-01 | 0.034 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.238999e-01 | 0.034 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.263159e-01 | 0.033 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.263159e-01 | 0.033 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.271772e-01 | 0.033 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.291766e-01 | 0.032 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.291766e-01 | 0.032 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.293010e-01 | 0.032 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.296414e-01 | 0.032 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.311869e-01 | 0.031 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.319264e-01 | 0.031 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.319264e-01 | 0.031 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.319264e-01 | 0.031 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.334671e-01 | 0.030 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.345696e-01 | 0.029 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.352254e-01 | 0.029 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.371103e-01 | 0.028 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.371103e-01 | 0.028 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.372903e-01 | 0.028 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.374244e-01 | 0.028 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.374244e-01 | 0.028 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.412342e-01 | 0.026 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.419000e-01 | 0.026 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.436737e-01 | 0.025 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.445825e-01 | 0.025 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.445825e-01 | 0.025 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.449419e-01 | 0.025 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.463254e-01 | 0.024 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.484102e-01 | 0.023 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.484102e-01 | 0.023 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.484102e-01 | 0.023 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.484102e-01 | 0.023 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.484263e-01 | 0.023 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.504142e-01 | 0.022 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.516999e-01 | 0.021 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.517777e-01 | 0.021 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.532614e-01 | 0.021 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.541921e-01 | 0.020 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.541921e-01 | 0.020 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.559624e-01 | 0.020 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.559718e-01 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.559718e-01 | 0.020 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.575343e-01 | 0.019 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.576825e-01 | 0.019 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.576825e-01 | 0.019 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.576825e-01 | 0.019 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.576825e-01 | 0.019 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.593268e-01 | 0.018 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.609073e-01 | 0.017 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.624265e-01 | 0.017 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.624265e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.624265e-01 | 0.017 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.629154e-01 | 0.016 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.647424e-01 | 0.016 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.652904e-01 | 0.015 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.669051e-01 | 0.015 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.696394e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.697984e-01 | 0.013 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.703807e-01 | 0.013 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.726391e-01 | 0.012 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.726391e-01 | 0.012 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.737030e-01 | 0.012 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.747743e-01 | 0.011 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.764119e-01 | 0.010 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.766531e-01 | 0.010 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.775611e-01 | 0.010 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.784339e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.800790e-01 | 0.009 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.805937e-01 | 0.009 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.830029e-01 | 0.007 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.834825e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.866051e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.871265e-01 | 0.006 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.876276e-01 | 0.005 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.878686e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.906306e-01 | 0.004 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.907551e-01 | 0.004 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.908790e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.910232e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.920073e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.922078e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.923186e-01 | 0.003 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.925870e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.937030e-01 | 0.003 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.944109e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.946051e-01 | 0.002 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.955972e-01 | 0.002 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.956300e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.959653e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.966673e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.967965e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.968139e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.969123e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.970424e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.971110e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.973091e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.975020e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.975976e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.979028e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.985557e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.988587e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.991216e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.993873e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.994668e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.997333e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998392e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999496e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999662e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999769e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999827e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999929e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999961e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999964e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999970e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999978e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999994e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.110223e-16 | 15.955 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 1 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.220446e-16 | 15.654 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.110223e-15 | 14.955 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.550316e-15 | 14.184 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.785861e-14 | 13.422 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.196643e-14 | 13.377 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.382184e-14 | 13.077 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.326673e-14 | 13.080 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.326673e-14 | 13.080 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.205702e-13 | 12.919 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.845813e-13 | 12.415 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.938272e-13 | 12.306 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.202505e-13 | 12.284 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.964118e-13 | 12.224 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.921130e-13 | 12.160 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.130207e-12 | 11.947 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.130207e-12 | 11.947 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.635247e-12 | 11.786 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.789791e-12 | 11.747 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.418399e-12 | 11.616 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.047229e-12 | 11.516 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.207434e-12 | 11.494 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.922862e-12 | 11.406 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.079781e-12 | 11.150 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.285927e-12 | 11.082 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.581802e-12 | 11.066 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.459877e-12 | 11.024 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.455103e-12 | 11.024 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.459877e-12 | 11.024 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.852563e-12 | 11.006 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.629219e-11 | 10.788 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.896228e-11 | 10.722 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.597511e-11 | 10.585 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.129241e-11 | 10.505 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.114897e-11 | 10.507 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.520007e-11 | 10.453 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.122236e-11 | 10.213 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.224365e-11 | 10.206 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.909628e-11 | 10.161 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.734979e-11 | 10.059 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.945222e-11 | 10.048 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.410950e-11 | 10.026 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.971801e-11 | 10.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.077146e-10 | 9.968 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.448214e-10 | 9.839 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.923708e-10 | 9.716 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.968229e-10 | 9.706 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.968229e-10 | 9.706 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.940275e-10 | 9.712 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.135242e-10 | 9.671 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.443766e-10 | 9.612 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.145584e-10 | 9.502 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.363183e-10 | 9.473 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.564523e-10 | 9.448 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.296390e-10 | 9.367 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.052153e-10 | 9.297 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.652543e-10 | 9.248 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.560209e-10 | 9.068 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.915287e-10 | 9.050 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.035724e-09 | 8.985 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.178069e-09 | 8.929 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.214829e-09 | 8.915 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.214829e-09 | 8.915 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.301637e-09 | 8.886 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.378495e-09 | 8.861 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.374190e-09 | 8.624 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.502364e-09 | 8.602 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.286208e-09 | 8.368 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.407634e-09 | 8.356 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.003074e-09 | 8.301 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.339527e-09 | 8.272 | 1 | 1 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.513179e-09 | 8.186 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.180677e-09 | 8.144 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.804392e-09 | 8.167 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.697588e-08 | 7.770 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.805675e-08 | 7.743 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.004194e-08 | 7.698 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.030272e-08 | 7.692 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.386671e-08 | 7.622 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.792819e-08 | 7.554 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.049203e-08 | 7.516 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.088105e-08 | 7.510 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.641809e-08 | 7.439 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.665178e-08 | 7.436 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.665178e-08 | 7.436 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.912375e-08 | 7.408 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.943495e-08 | 7.404 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.560749e-08 | 7.341 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.578016e-08 | 7.339 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.591397e-08 | 7.338 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.936690e-08 | 7.307 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.936690e-08 | 7.307 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.526423e-08 | 7.258 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.743045e-08 | 7.241 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.757614e-08 | 7.240 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.958438e-08 | 7.157 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.773998e-08 | 7.109 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.538702e-08 | 7.021 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.538702e-08 | 7.021 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.210498e-07 | 6.917 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.643171e-07 | 6.784 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.643171e-07 | 6.784 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.325843e-07 | 6.633 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.569984e-07 | 6.590 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.569984e-07 | 6.590 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.569984e-07 | 6.590 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.569984e-07 | 6.590 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.574521e-07 | 6.589 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.775348e-07 | 6.557 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.015572e-07 | 6.521 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.362594e-07 | 6.473 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.374485e-07 | 6.472 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.445017e-07 | 6.463 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.623330e-07 | 6.441 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.630271e-07 | 6.440 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.138130e-07 | 6.383 | 0 | 0 |
| Translation | R-HSA-72766 | 4.330549e-07 | 6.363 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.649633e-07 | 6.333 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.920086e-07 | 6.308 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.185933e-07 | 6.209 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.202603e-07 | 6.086 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.400614e-07 | 6.076 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.428319e-07 | 6.026 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.877952e-07 | 6.005 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.877952e-07 | 6.005 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.268507e-06 | 5.897 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.296568e-06 | 5.887 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.899618e-06 | 5.721 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.406401e-06 | 5.619 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.418424e-06 | 5.616 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.989126e-06 | 5.524 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.024883e-06 | 5.519 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.477029e-06 | 5.459 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.477424e-06 | 5.459 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.672781e-06 | 5.435 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.672781e-06 | 5.435 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.874776e-06 | 5.312 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.082614e-06 | 5.294 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.237076e-06 | 5.281 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.237076e-06 | 5.281 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.691167e-06 | 5.245 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.627955e-06 | 5.179 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.681197e-06 | 5.175 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.685696e-06 | 5.175 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.737672e-06 | 5.171 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.803007e-06 | 5.167 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.139389e-06 | 5.146 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.261594e-06 | 5.139 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.782740e-06 | 5.109 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.632691e-06 | 5.064 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.843215e-06 | 5.053 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.006560e-05 | 4.997 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.003011e-05 | 4.999 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.064229e-05 | 4.973 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.064963e-05 | 4.973 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.064963e-05 | 4.973 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.064963e-05 | 4.973 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.096679e-05 | 4.960 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.235430e-05 | 4.908 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.259175e-05 | 4.900 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.310179e-05 | 4.883 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.322670e-05 | 4.879 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.322670e-05 | 4.879 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.352207e-05 | 4.869 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.403351e-05 | 4.853 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.661846e-05 | 4.779 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.801930e-05 | 4.744 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.864864e-05 | 4.729 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.886891e-05 | 4.724 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.934940e-05 | 4.713 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.979381e-05 | 4.703 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.487266e-05 | 4.604 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.487266e-05 | 4.604 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.459562e-05 | 4.609 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.413984e-05 | 4.617 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.230444e-05 | 4.652 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.230444e-05 | 4.652 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.531439e-05 | 4.597 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.531439e-05 | 4.597 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.531439e-05 | 4.597 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.544111e-05 | 4.594 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.872909e-05 | 4.542 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.987738e-05 | 4.525 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.220519e-05 | 4.492 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.233086e-05 | 4.490 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.492090e-05 | 4.457 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.560852e-05 | 4.448 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.074165e-05 | 4.390 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.626027e-05 | 4.335 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.626027e-05 | 4.335 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.651491e-05 | 4.332 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.779684e-05 | 4.321 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.915269e-05 | 4.308 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.915269e-05 | 4.308 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.136396e-05 | 4.289 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.250161e-05 | 4.280 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.738857e-05 | 4.241 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.740235e-05 | 4.241 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.479184e-05 | 4.126 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.368368e-05 | 4.133 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.368368e-05 | 4.133 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.869614e-05 | 4.163 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.135189e-05 | 4.147 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.479184e-05 | 4.126 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.867838e-05 | 4.104 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.936703e-05 | 4.100 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.664817e-05 | 4.062 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.445117e-05 | 4.025 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.605712e-05 | 4.017 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.017993e-04 | 3.992 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.054098e-04 | 3.977 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.076114e-04 | 3.968 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.084982e-04 | 3.965 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.120136e-04 | 3.951 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.139176e-04 | 3.943 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.150443e-04 | 3.939 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.150443e-04 | 3.939 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.175628e-04 | 3.930 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.181357e-04 | 3.928 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.355647e-04 | 3.868 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.620195e-04 | 3.790 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.639335e-04 | 3.785 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.802948e-04 | 3.744 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.909894e-04 | 3.719 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.110260e-04 | 3.676 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.119902e-04 | 3.674 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.145015e-04 | 3.669 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.145015e-04 | 3.669 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.145015e-04 | 3.669 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.219049e-04 | 3.654 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.275043e-04 | 3.643 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.275043e-04 | 3.643 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.369470e-04 | 3.625 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.789362e-04 | 3.554 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.789362e-04 | 3.554 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.940394e-04 | 3.532 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.940394e-04 | 3.532 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.940394e-04 | 3.532 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.940394e-04 | 3.532 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.113991e-04 | 3.507 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.113991e-04 | 3.507 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.188791e-04 | 3.496 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.221867e-04 | 3.492 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.246459e-04 | 3.489 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.246459e-04 | 3.489 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.420100e-04 | 3.466 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.420100e-04 | 3.466 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.486991e-04 | 3.458 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.498865e-04 | 3.456 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.500750e-04 | 3.456 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.516701e-04 | 3.454 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.651507e-04 | 3.438 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.874205e-04 | 3.412 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.168554e-04 | 3.380 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.168554e-04 | 3.380 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.168554e-04 | 3.380 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.280536e-04 | 3.369 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.358641e-04 | 3.361 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.559262e-04 | 3.341 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.559262e-04 | 3.341 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.571092e-04 | 3.340 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.571092e-04 | 3.340 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.685610e-04 | 3.329 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.858099e-04 | 3.314 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.228660e-04 | 3.282 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.228660e-04 | 3.282 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.228660e-04 | 3.282 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.228660e-04 | 3.282 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.236262e-04 | 3.281 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.254370e-04 | 3.279 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.376534e-04 | 3.269 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.450483e-04 | 3.264 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.060503e-04 | 3.151 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.730020e-04 | 3.172 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.306264e-04 | 3.200 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.913778e-04 | 3.228 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.018043e-04 | 3.221 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.639246e-04 | 3.178 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.414470e-04 | 3.193 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.060503e-04 | 3.151 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.639246e-04 | 3.178 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.099335e-04 | 3.149 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.109842e-04 | 3.091 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.308574e-04 | 3.080 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.502560e-04 | 3.070 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.546498e-04 | 3.068 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.861201e-04 | 3.053 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.970250e-04 | 3.047 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.970250e-04 | 3.047 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.970250e-04 | 3.047 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.970250e-04 | 3.047 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.970250e-04 | 3.047 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.970250e-04 | 3.047 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 9.115172e-04 | 3.040 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.115172e-04 | 3.040 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 9.115172e-04 | 3.040 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.852846e-04 | 3.006 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.879996e-04 | 3.005 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.001785e-03 | 2.999 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.082533e-03 | 2.966 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.096712e-03 | 2.960 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.123992e-03 | 2.949 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.137191e-03 | 2.944 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.303496e-03 | 2.885 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.390911e-03 | 2.857 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.400971e-03 | 2.854 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.422348e-03 | 2.847 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.523243e-03 | 2.817 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.586752e-03 | 2.799 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.675274e-03 | 2.776 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.675274e-03 | 2.776 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.692765e-03 | 2.771 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.701843e-03 | 2.769 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.701843e-03 | 2.769 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.701843e-03 | 2.769 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.843819e-03 | 2.734 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.843819e-03 | 2.734 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.853890e-03 | 2.732 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.855490e-03 | 2.732 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.031774e-03 | 2.692 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.060924e-03 | 2.686 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.166863e-03 | 2.664 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.166863e-03 | 2.664 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.472345e-03 | 2.607 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.472345e-03 | 2.607 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.439352e-03 | 2.613 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.425248e-03 | 2.615 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.472345e-03 | 2.607 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.737475e-03 | 2.563 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.462513e-03 | 2.609 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.479607e-03 | 2.606 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.439352e-03 | 2.613 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.439352e-03 | 2.613 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.687895e-03 | 2.571 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.361779e-03 | 2.627 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.940334e-03 | 2.532 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.737475e-03 | 2.563 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.798113e-03 | 2.553 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.662345e-03 | 2.575 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.425248e-03 | 2.615 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.798113e-03 | 2.553 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.282464e-03 | 2.642 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.559895e-03 | 2.592 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.737475e-03 | 2.563 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.249590e-03 | 2.488 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.250466e-03 | 2.488 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.416783e-03 | 2.466 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.416828e-03 | 2.466 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.467045e-03 | 2.460 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.467045e-03 | 2.460 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.467045e-03 | 2.460 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.469132e-03 | 2.460 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.469132e-03 | 2.460 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.516417e-03 | 2.454 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.516417e-03 | 2.454 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.516417e-03 | 2.454 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.516417e-03 | 2.454 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.516417e-03 | 2.454 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.569179e-03 | 2.447 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.585492e-03 | 2.445 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.695373e-03 | 2.432 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.738379e-03 | 2.427 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.801228e-03 | 2.420 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.815303e-03 | 2.418 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.844087e-03 | 2.415 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.911566e-03 | 2.408 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.062975e-03 | 2.391 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.062975e-03 | 2.391 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.062975e-03 | 2.391 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.062975e-03 | 2.391 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.062975e-03 | 2.391 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.062975e-03 | 2.391 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.078026e-03 | 2.390 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.184986e-03 | 2.378 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.217597e-03 | 2.375 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.217597e-03 | 2.375 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.217597e-03 | 2.375 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.350649e-03 | 2.361 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.350649e-03 | 2.361 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.576662e-03 | 2.339 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.576662e-03 | 2.339 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.639686e-03 | 2.334 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.667573e-03 | 2.331 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.667573e-03 | 2.331 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.667573e-03 | 2.331 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.671932e-03 | 2.331 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.726075e-03 | 2.325 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.152810e-03 | 2.288 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.176083e-03 | 2.286 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.305699e-03 | 2.275 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.305699e-03 | 2.275 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.308896e-03 | 2.275 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.308896e-03 | 2.275 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.540861e-03 | 2.256 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.550098e-03 | 2.256 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.703388e-03 | 2.244 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.036825e-03 | 2.219 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.627809e-03 | 2.118 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.941812e-03 | 2.226 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.898466e-03 | 2.051 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.898466e-03 | 2.051 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.398856e-03 | 2.194 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.276668e-03 | 2.202 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.770132e-03 | 2.169 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.398856e-03 | 2.194 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.770132e-03 | 2.169 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.183112e-03 | 2.087 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.036825e-03 | 2.219 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.425231e-03 | 2.192 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.836794e-03 | 2.165 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.166477e-03 | 2.088 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.172305e-03 | 2.144 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.398856e-03 | 2.194 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.308246e-03 | 2.080 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.634793e-03 | 2.117 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.166477e-03 | 2.088 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.308246e-03 | 2.080 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.894692e-03 | 2.051 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.462149e-03 | 2.073 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.631764e-03 | 2.178 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.068631e-03 | 2.151 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.631764e-03 | 2.178 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.183112e-03 | 2.087 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.693952e-03 | 2.114 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.836794e-03 | 2.165 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.836794e-03 | 2.165 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.378042e-03 | 2.132 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.183112e-03 | 2.087 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.627809e-03 | 2.118 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.405514e-03 | 2.075 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.627809e-03 | 2.118 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.938095e-03 | 2.049 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.938095e-03 | 2.049 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.002582e-03 | 2.046 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.002582e-03 | 2.046 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.002582e-03 | 2.046 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.002582e-03 | 2.046 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.002582e-03 | 2.046 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.002582e-03 | 2.046 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.049415e-03 | 2.043 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.049415e-03 | 2.043 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.223966e-03 | 2.035 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.537920e-03 | 2.021 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.537920e-03 | 2.021 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.979357e-03 | 2.001 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.979357e-03 | 2.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.009423e-02 | 1.996 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.034263e-02 | 1.985 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.038755e-02 | 1.983 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.038755e-02 | 1.983 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.046698e-02 | 1.980 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.046698e-02 | 1.980 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.052953e-02 | 1.978 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.052953e-02 | 1.978 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.052953e-02 | 1.978 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.097530e-02 | 1.960 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.097530e-02 | 1.960 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.097530e-02 | 1.960 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.105196e-02 | 1.957 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.105196e-02 | 1.957 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.128610e-02 | 1.947 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.164780e-02 | 1.934 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.164780e-02 | 1.934 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.164780e-02 | 1.934 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.221452e-02 | 1.913 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.221452e-02 | 1.913 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.252836e-02 | 1.902 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.262672e-02 | 1.899 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.300816e-02 | 1.886 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.317445e-02 | 1.880 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.317445e-02 | 1.880 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.317445e-02 | 1.880 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.395687e-02 | 1.855 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.395687e-02 | 1.855 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.438214e-02 | 1.842 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.438214e-02 | 1.842 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.438214e-02 | 1.842 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.447193e-02 | 1.839 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.447193e-02 | 1.839 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.447193e-02 | 1.839 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.447193e-02 | 1.839 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.447193e-02 | 1.839 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.447193e-02 | 1.839 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.450004e-02 | 1.839 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.487327e-02 | 1.828 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.487327e-02 | 1.828 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.547209e-02 | 1.810 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.566479e-02 | 1.805 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.568456e-02 | 1.805 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.597584e-02 | 1.797 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.607958e-02 | 1.794 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.607958e-02 | 1.794 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.607958e-02 | 1.794 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.667472e-02 | 1.778 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.702448e-02 | 1.769 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.702448e-02 | 1.769 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.702448e-02 | 1.769 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.772206e-02 | 1.751 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.772206e-02 | 1.751 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.772206e-02 | 1.751 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.772206e-02 | 1.751 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.779606e-02 | 1.750 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.779606e-02 | 1.750 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.826884e-02 | 1.738 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.826884e-02 | 1.738 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.826884e-02 | 1.738 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.831592e-02 | 1.737 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.831592e-02 | 1.737 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.846323e-02 | 1.734 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.867081e-02 | 1.729 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.907014e-02 | 1.720 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.926127e-02 | 1.715 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.929908e-02 | 1.714 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.951418e-02 | 1.710 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.951418e-02 | 1.710 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.951418e-02 | 1.710 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.951418e-02 | 1.710 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.998298e-02 | 1.699 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.021655e-02 | 1.694 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.021655e-02 | 1.694 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.021655e-02 | 1.694 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.024190e-02 | 1.694 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.024190e-02 | 1.694 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.028718e-02 | 1.693 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.040675e-02 | 1.690 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.063453e-02 | 1.685 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.063453e-02 | 1.685 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.088951e-02 | 1.680 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.104988e-02 | 1.677 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.104988e-02 | 1.677 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.104988e-02 | 1.677 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.142121e-02 | 1.669 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.142121e-02 | 1.669 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.142121e-02 | 1.669 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.142121e-02 | 1.669 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.142121e-02 | 1.669 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.142121e-02 | 1.669 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.180728e-02 | 1.661 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.231661e-02 | 1.651 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.240677e-02 | 1.650 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.240677e-02 | 1.650 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.317995e-02 | 1.635 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.317995e-02 | 1.635 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.320661e-02 | 1.634 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.327281e-02 | 1.633 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.340243e-02 | 1.631 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.344557e-02 | 1.630 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.344557e-02 | 1.630 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.344557e-02 | 1.630 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.395192e-02 | 1.621 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.395192e-02 | 1.621 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.395192e-02 | 1.621 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.443151e-02 | 1.612 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.443151e-02 | 1.612 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.452695e-02 | 1.610 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.504635e-02 | 1.601 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.558948e-02 | 1.592 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.570170e-02 | 1.590 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.570170e-02 | 1.590 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.570170e-02 | 1.590 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.690500e-02 | 1.570 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.690778e-02 | 1.570 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.785499e-02 | 1.555 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.785499e-02 | 1.555 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.785499e-02 | 1.555 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.785499e-02 | 1.555 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.785499e-02 | 1.555 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.807437e-02 | 1.552 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.882072e-02 | 1.540 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.885862e-02 | 1.540 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.885862e-02 | 1.540 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.946254e-02 | 1.531 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.975181e-02 | 1.526 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.024391e-02 | 1.519 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.089132e-02 | 1.510 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.090027e-02 | 1.510 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.192018e-02 | 1.496 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.192018e-02 | 1.496 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.228040e-02 | 1.491 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.275790e-02 | 1.485 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.303402e-02 | 1.481 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.303402e-02 | 1.481 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 3.735312e-02 | 1.428 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 3.735312e-02 | 1.428 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 3.735312e-02 | 1.428 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.791170e-02 | 1.421 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.681554e-02 | 1.330 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.639654e-02 | 1.249 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.639654e-02 | 1.249 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.659188e-02 | 1.177 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.659188e-02 | 1.177 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.659188e-02 | 1.177 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.659188e-02 | 1.177 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.693948e-02 | 1.433 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.693948e-02 | 1.433 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.192318e-02 | 1.378 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.868394e-02 | 1.412 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.758258e-02 | 1.425 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.750179e-02 | 1.240 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.750179e-02 | 1.240 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.251269e-02 | 1.371 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.350109e-02 | 1.197 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.816658e-02 | 1.418 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.695252e-02 | 1.432 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.526109e-02 | 1.453 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.602871e-02 | 1.252 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.758258e-02 | 1.425 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.791170e-02 | 1.421 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.659188e-02 | 1.177 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.106353e-02 | 1.387 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.118183e-02 | 1.213 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.749145e-02 | 1.426 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.639451e-02 | 1.439 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.498229e-02 | 1.187 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.659188e-02 | 1.177 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.241205e-02 | 1.373 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.350615e-02 | 1.475 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.350615e-02 | 1.475 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.620432e-02 | 1.335 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.498229e-02 | 1.187 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.350109e-02 | 1.197 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.234951e-02 | 1.373 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.106353e-02 | 1.387 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.512300e-02 | 1.346 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.512300e-02 | 1.346 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.730285e-02 | 1.325 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.722612e-02 | 1.326 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.498229e-02 | 1.187 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.750179e-02 | 1.240 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.804567e-02 | 1.420 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.741058e-02 | 1.241 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.106353e-02 | 1.387 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.106353e-02 | 1.387 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.285456e-02 | 1.202 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.340298e-02 | 1.476 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.466563e-02 | 1.350 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.620432e-02 | 1.335 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.256424e-02 | 1.279 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.967044e-02 | 1.402 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.210374e-02 | 1.376 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.659188e-02 | 1.177 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.350109e-02 | 1.197 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.395255e-02 | 1.268 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.354278e-02 | 1.271 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.889773e-02 | 1.230 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.539838e-02 | 1.451 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.816658e-02 | 1.418 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.520763e-02 | 1.453 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.758258e-02 | 1.425 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.868394e-02 | 1.412 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.816658e-02 | 1.418 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.395255e-02 | 1.268 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.350615e-02 | 1.475 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.423228e-02 | 1.192 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.791170e-02 | 1.421 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.639654e-02 | 1.249 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.988649e-02 | 1.223 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.395255e-02 | 1.268 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.395255e-02 | 1.268 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.758258e-02 | 1.425 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.526109e-02 | 1.453 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.482915e-02 | 1.261 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.934394e-02 | 1.227 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.758258e-02 | 1.425 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.520763e-02 | 1.453 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.489447e-02 | 1.260 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.620432e-02 | 1.335 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.771245e-02 | 1.169 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.828760e-02 | 1.166 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.846836e-02 | 1.165 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.892049e-02 | 1.162 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.893285e-02 | 1.162 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.091983e-02 | 1.149 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.091983e-02 | 1.149 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.145705e-02 | 1.146 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.145705e-02 | 1.146 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.149016e-02 | 1.146 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.149016e-02 | 1.146 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.149016e-02 | 1.146 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.319804e-02 | 1.136 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.325496e-02 | 1.135 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.325496e-02 | 1.135 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 7.331318e-02 | 1.135 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.331318e-02 | 1.135 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 7.331318e-02 | 1.135 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 7.331318e-02 | 1.135 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 7.331318e-02 | 1.135 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 7.331318e-02 | 1.135 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 7.331318e-02 | 1.135 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 7.331318e-02 | 1.135 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.331318e-02 | 1.135 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.404716e-02 | 1.130 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.725463e-02 | 1.112 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.734245e-02 | 1.112 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.734245e-02 | 1.112 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 7.734245e-02 | 1.112 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.734245e-02 | 1.112 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.734245e-02 | 1.112 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.734245e-02 | 1.112 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.734245e-02 | 1.112 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.734245e-02 | 1.112 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.734245e-02 | 1.112 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.734245e-02 | 1.112 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.876285e-02 | 1.104 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.941076e-02 | 1.100 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.941076e-02 | 1.100 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.036354e-02 | 1.095 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.289032e-02 | 1.081 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.516907e-02 | 1.070 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.597842e-02 | 1.066 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.597842e-02 | 1.066 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.735637e-02 | 1.059 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.805787e-02 | 1.055 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.859272e-02 | 1.053 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.859272e-02 | 1.053 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.859272e-02 | 1.053 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.205101e-02 | 1.036 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.205101e-02 | 1.036 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.448768e-02 | 1.025 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.814237e-02 | 1.008 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.000776e-01 | 1.000 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.000776e-01 | 1.000 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.002184e-01 | 0.999 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.002905e-01 | 0.999 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.002905e-01 | 0.999 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.002905e-01 | 0.999 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.002905e-01 | 0.999 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.003255e-01 | 0.999 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.007038e-01 | 0.997 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.007038e-01 | 0.997 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.030731e-01 | 0.987 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.065365e-01 | 0.973 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.066920e-01 | 0.972 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.066920e-01 | 0.972 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.066920e-01 | 0.972 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.079320e-01 | 0.967 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.079320e-01 | 0.967 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.079320e-01 | 0.967 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.079320e-01 | 0.967 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.079320e-01 | 0.967 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.079320e-01 | 0.967 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 1.079320e-01 | 0.967 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.080230e-01 | 0.966 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.080230e-01 | 0.966 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.123867e-01 | 0.949 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.123867e-01 | 0.949 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.123867e-01 | 0.949 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.123867e-01 | 0.949 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.123867e-01 | 0.949 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.123867e-01 | 0.949 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.123867e-01 | 0.949 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.128375e-01 | 0.948 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.133640e-01 | 0.946 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.134440e-01 | 0.945 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.145844e-01 | 0.941 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 1.152566e-01 | 0.938 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.152566e-01 | 0.938 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.160551e-01 | 0.935 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.160551e-01 | 0.935 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.169829e-01 | 0.932 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.180010e-01 | 0.928 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.191357e-01 | 0.924 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.222888e-01 | 0.913 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.243035e-01 | 0.906 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.248355e-01 | 0.904 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.248355e-01 | 0.904 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.255824e-01 | 0.901 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.255824e-01 | 0.901 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.255824e-01 | 0.901 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.259493e-01 | 0.900 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.259493e-01 | 0.900 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.280097e-01 | 0.893 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.321730e-01 | 0.879 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.327568e-01 | 0.877 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.327568e-01 | 0.877 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.347551e-01 | 0.870 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.347551e-01 | 0.870 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.370797e-01 | 0.863 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.375937e-01 | 0.861 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.375937e-01 | 0.861 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.375937e-01 | 0.861 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.375937e-01 | 0.861 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.389026e-01 | 0.857 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.412597e-01 | 0.850 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.412597e-01 | 0.850 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 1.412597e-01 | 0.850 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.412597e-01 | 0.850 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.412597e-01 | 0.850 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.412597e-01 | 0.850 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 1.412597e-01 | 0.850 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.412597e-01 | 0.850 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.412597e-01 | 0.850 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.412597e-01 | 0.850 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.414038e-01 | 0.850 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.421094e-01 | 0.847 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.457665e-01 | 0.836 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.457665e-01 | 0.836 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.457665e-01 | 0.836 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.463625e-01 | 0.835 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.502332e-01 | 0.823 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 1.502332e-01 | 0.823 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.506210e-01 | 0.822 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.527596e-01 | 0.816 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.528988e-01 | 0.816 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.575793e-01 | 0.803 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.592336e-01 | 0.798 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.605718e-01 | 0.794 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.623751e-01 | 0.789 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.638795e-01 | 0.785 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.638795e-01 | 0.785 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.638795e-01 | 0.785 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.638795e-01 | 0.785 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.638795e-01 | 0.785 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.638795e-01 | 0.785 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.663251e-01 | 0.779 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.666854e-01 | 0.778 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.671136e-01 | 0.777 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.671136e-01 | 0.777 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.721084e-01 | 0.764 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.733441e-01 | 0.761 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.733441e-01 | 0.761 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.733441e-01 | 0.761 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.733441e-01 | 0.761 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 1.733441e-01 | 0.761 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.733441e-01 | 0.761 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 1.733441e-01 | 0.761 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.733441e-01 | 0.761 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.737475e-01 | 0.760 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.744640e-01 | 0.758 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.770682e-01 | 0.752 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.773338e-01 | 0.751 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.773338e-01 | 0.751 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.773338e-01 | 0.751 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.773338e-01 | 0.751 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.773338e-01 | 0.751 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 1.777025e-01 | 0.750 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.777025e-01 | 0.750 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.777025e-01 | 0.750 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.793659e-01 | 0.746 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.793659e-01 | 0.746 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.848896e-01 | 0.733 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.855576e-01 | 0.732 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.871487e-01 | 0.728 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.909509e-01 | 0.719 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.909509e-01 | 0.719 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.967216e-01 | 0.706 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 1.967216e-01 | 0.706 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.985512e-01 | 0.702 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.016897e-01 | 0.695 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.042317e-01 | 0.690 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.042317e-01 | 0.690 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.042317e-01 | 0.690 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.042317e-01 | 0.690 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.042317e-01 | 0.690 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.042317e-01 | 0.690 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.042317e-01 | 0.690 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.042317e-01 | 0.690 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.042317e-01 | 0.690 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.047000e-01 | 0.689 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.047000e-01 | 0.689 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.052184e-01 | 0.688 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.079741e-01 | 0.682 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.162042e-01 | 0.665 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.162042e-01 | 0.665 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.185522e-01 | 0.660 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.185522e-01 | 0.660 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.185522e-01 | 0.660 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.185522e-01 | 0.660 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.254149e-01 | 0.647 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.260931e-01 | 0.646 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.314569e-01 | 0.636 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.324808e-01 | 0.634 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.324808e-01 | 0.634 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.324808e-01 | 0.634 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.339670e-01 | 0.631 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.339670e-01 | 0.631 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.339670e-01 | 0.631 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.339670e-01 | 0.631 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 2.339670e-01 | 0.631 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.339670e-01 | 0.631 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.339670e-01 | 0.631 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.339670e-01 | 0.631 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.381576e-01 | 0.623 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.413477e-01 | 0.617 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.443496e-01 | 0.612 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.444993e-01 | 0.612 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.461151e-01 | 0.609 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.464606e-01 | 0.608 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.464606e-01 | 0.608 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.502904e-01 | 0.602 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.530726e-01 | 0.597 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.562286e-01 | 0.591 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.604686e-01 | 0.584 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.604686e-01 | 0.584 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.604686e-01 | 0.584 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.604686e-01 | 0.584 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.604686e-01 | 0.584 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.613276e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.613276e-01 | 0.583 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.613276e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.613276e-01 | 0.583 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.613276e-01 | 0.583 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.613276e-01 | 0.583 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.625929e-01 | 0.581 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.625929e-01 | 0.581 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.625929e-01 | 0.581 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.625929e-01 | 0.581 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.625929e-01 | 0.581 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.625929e-01 | 0.581 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.625929e-01 | 0.581 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.625929e-01 | 0.581 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.625929e-01 | 0.581 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.625929e-01 | 0.581 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 2.625929e-01 | 0.581 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.625929e-01 | 0.581 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.675153e-01 | 0.573 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.696333e-01 | 0.569 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.703202e-01 | 0.568 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.744831e-01 | 0.561 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.744831e-01 | 0.561 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.744831e-01 | 0.561 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.752213e-01 | 0.560 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.779849e-01 | 0.556 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.818287e-01 | 0.550 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.824026e-01 | 0.549 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.884841e-01 | 0.540 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.884841e-01 | 0.540 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.884841e-01 | 0.540 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.884841e-01 | 0.540 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.884841e-01 | 0.540 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.891883e-01 | 0.539 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.901508e-01 | 0.537 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.901508e-01 | 0.537 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.901508e-01 | 0.537 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.901508e-01 | 0.537 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.901508e-01 | 0.537 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.901508e-01 | 0.537 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.901508e-01 | 0.537 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.901508e-01 | 0.537 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.901508e-01 | 0.537 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.901508e-01 | 0.537 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.971493e-01 | 0.527 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.971493e-01 | 0.527 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.004993e-01 | 0.522 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.024531e-01 | 0.519 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.047434e-01 | 0.516 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.084643e-01 | 0.511 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.114213e-01 | 0.507 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.114213e-01 | 0.507 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.163731e-01 | 0.500 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.163731e-01 | 0.500 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.166804e-01 | 0.499 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.166804e-01 | 0.499 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.166804e-01 | 0.499 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.166804e-01 | 0.499 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.166804e-01 | 0.499 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.166804e-01 | 0.499 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 3.166804e-01 | 0.499 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.166804e-01 | 0.499 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.166804e-01 | 0.499 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.166804e-01 | 0.499 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.166804e-01 | 0.499 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.166804e-01 | 0.499 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.166804e-01 | 0.499 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.166804e-01 | 0.499 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.177677e-01 | 0.498 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.212090e-01 | 0.493 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.280879e-01 | 0.484 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.280879e-01 | 0.484 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.302281e-01 | 0.481 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.302281e-01 | 0.481 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.302281e-01 | 0.481 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.302281e-01 | 0.481 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.338564e-01 | 0.476 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.373192e-01 | 0.472 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.384054e-01 | 0.471 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.401713e-01 | 0.468 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.422201e-01 | 0.466 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.422201e-01 | 0.466 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 3.422201e-01 | 0.466 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.422201e-01 | 0.466 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.422201e-01 | 0.466 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.422201e-01 | 0.466 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.422201e-01 | 0.466 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.422201e-01 | 0.466 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.422201e-01 | 0.466 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.440036e-01 | 0.463 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.440036e-01 | 0.463 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.440036e-01 | 0.463 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.440036e-01 | 0.463 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.482214e-01 | 0.458 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.482214e-01 | 0.458 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.548474e-01 | 0.450 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.576863e-01 | 0.446 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.590034e-01 | 0.445 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.629623e-01 | 0.440 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.629623e-01 | 0.440 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.668067e-01 | 0.436 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.668067e-01 | 0.436 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.668067e-01 | 0.436 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.668067e-01 | 0.436 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.668067e-01 | 0.436 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.668067e-01 | 0.436 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.668067e-01 | 0.436 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.668067e-01 | 0.436 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.712639e-01 | 0.430 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.712639e-01 | 0.430 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.837738e-01 | 0.416 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.847251e-01 | 0.415 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.885671e-01 | 0.411 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 3.897081e-01 | 0.409 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.899170e-01 | 0.409 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.899170e-01 | 0.409 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.899170e-01 | 0.409 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.904758e-01 | 0.408 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.904758e-01 | 0.408 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.904758e-01 | 0.408 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 3.904758e-01 | 0.408 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 3.904758e-01 | 0.408 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.904758e-01 | 0.408 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.904758e-01 | 0.408 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.904758e-01 | 0.408 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.904758e-01 | 0.408 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 3.904758e-01 | 0.408 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.951319e-01 | 0.403 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.970752e-01 | 0.401 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.980597e-01 | 0.400 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.980597e-01 | 0.400 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.998669e-01 | 0.398 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.998669e-01 | 0.398 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.078506e-01 | 0.389 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.085339e-01 | 0.389 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.099783e-01 | 0.387 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.112584e-01 | 0.386 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.112584e-01 | 0.386 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.119792e-01 | 0.385 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.132615e-01 | 0.384 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 4.132615e-01 | 0.384 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.132615e-01 | 0.384 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.132615e-01 | 0.384 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.132615e-01 | 0.384 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.132615e-01 | 0.384 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.132615e-01 | 0.384 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.132615e-01 | 0.384 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.132615e-01 | 0.384 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.132615e-01 | 0.384 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.132615e-01 | 0.384 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.132615e-01 | 0.384 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.206231e-01 | 0.376 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.226865e-01 | 0.374 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.351967e-01 | 0.361 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.351967e-01 | 0.361 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.351967e-01 | 0.361 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.351967e-01 | 0.361 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.351967e-01 | 0.361 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.351967e-01 | 0.361 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.351967e-01 | 0.361 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.372149e-01 | 0.359 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.450891e-01 | 0.352 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.499583e-01 | 0.347 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.563132e-01 | 0.341 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.563132e-01 | 0.341 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.563132e-01 | 0.341 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.563132e-01 | 0.341 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.563132e-01 | 0.341 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.563132e-01 | 0.341 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.563132e-01 | 0.341 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.563132e-01 | 0.341 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.563132e-01 | 0.341 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.563132e-01 | 0.341 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.563132e-01 | 0.341 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.572588e-01 | 0.340 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.625367e-01 | 0.335 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.625367e-01 | 0.335 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.625367e-01 | 0.335 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 4.634563e-01 | 0.334 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.766414e-01 | 0.322 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.766414e-01 | 0.322 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.766414e-01 | 0.322 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.766414e-01 | 0.322 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.766414e-01 | 0.322 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.766414e-01 | 0.322 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.790147e-01 | 0.320 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.871771e-01 | 0.312 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.871771e-01 | 0.312 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.885765e-01 | 0.311 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 4.886514e-01 | 0.311 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.943902e-01 | 0.306 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.962107e-01 | 0.304 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.962107e-01 | 0.304 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.962107e-01 | 0.304 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.962107e-01 | 0.304 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.962107e-01 | 0.304 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.962107e-01 | 0.304 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.962107e-01 | 0.304 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.980521e-01 | 0.303 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.096644e-01 | 0.293 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.150495e-01 | 0.288 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.150495e-01 | 0.288 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.150495e-01 | 0.288 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.150495e-01 | 0.288 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.150495e-01 | 0.288 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.150495e-01 | 0.288 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.150495e-01 | 0.288 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 5.205739e-01 | 0.284 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 5.227833e-01 | 0.282 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.331849e-01 | 0.273 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.331849e-01 | 0.273 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.331849e-01 | 0.273 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.331849e-01 | 0.273 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.331849e-01 | 0.273 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.331849e-01 | 0.273 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.331849e-01 | 0.273 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.331849e-01 | 0.273 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.342778e-01 | 0.272 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.385230e-01 | 0.269 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.440347e-01 | 0.264 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.443541e-01 | 0.264 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.455810e-01 | 0.263 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.506432e-01 | 0.259 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.506432e-01 | 0.259 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.506432e-01 | 0.259 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.506432e-01 | 0.259 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.506432e-01 | 0.259 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.506432e-01 | 0.259 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.515235e-01 | 0.258 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.529344e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.566912e-01 | 0.254 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.579030e-01 | 0.253 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.590951e-01 | 0.253 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.590951e-01 | 0.253 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.674495e-01 | 0.246 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.674495e-01 | 0.246 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.674495e-01 | 0.246 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.674495e-01 | 0.246 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.676071e-01 | 0.246 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.783275e-01 | 0.238 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.790033e-01 | 0.237 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.836283e-01 | 0.234 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.836283e-01 | 0.234 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.836283e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.836283e-01 | 0.234 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.836283e-01 | 0.234 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.836283e-01 | 0.234 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.836283e-01 | 0.234 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.836283e-01 | 0.234 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.836283e-01 | 0.234 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.836283e-01 | 0.234 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.874775e-01 | 0.231 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.888520e-01 | 0.230 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.958840e-01 | 0.225 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.972985e-01 | 0.224 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.991801e-01 | 0.222 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.992029e-01 | 0.222 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.992029e-01 | 0.222 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.992029e-01 | 0.222 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.992029e-01 | 0.222 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.992029e-01 | 0.222 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.992029e-01 | 0.222 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.992029e-01 | 0.222 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.093118e-01 | 0.215 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.093118e-01 | 0.215 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.093118e-01 | 0.215 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.141959e-01 | 0.212 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.141959e-01 | 0.212 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.141959e-01 | 0.212 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.141959e-01 | 0.212 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.141959e-01 | 0.212 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.141959e-01 | 0.212 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.192474e-01 | 0.208 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.286289e-01 | 0.202 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.286289e-01 | 0.202 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.286289e-01 | 0.202 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.286289e-01 | 0.202 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.286289e-01 | 0.202 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.286289e-01 | 0.202 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 6.286289e-01 | 0.202 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.359767e-01 | 0.197 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.404582e-01 | 0.194 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.425227e-01 | 0.192 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.425227e-01 | 0.192 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.425227e-01 | 0.192 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 6.425227e-01 | 0.192 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.425227e-01 | 0.192 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.425227e-01 | 0.192 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.466212e-01 | 0.189 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.478832e-01 | 0.189 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.558976e-01 | 0.183 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 6.558976e-01 | 0.183 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.558976e-01 | 0.183 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.586857e-01 | 0.181 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.658970e-01 | 0.177 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.660080e-01 | 0.177 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.687729e-01 | 0.175 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.687729e-01 | 0.175 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.687729e-01 | 0.175 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.687729e-01 | 0.175 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.687729e-01 | 0.175 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.747846e-01 | 0.171 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.747846e-01 | 0.171 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.811672e-01 | 0.167 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.811672e-01 | 0.167 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.811672e-01 | 0.167 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.811672e-01 | 0.167 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.811672e-01 | 0.167 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.811672e-01 | 0.167 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.811672e-01 | 0.167 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.811672e-01 | 0.167 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.930984e-01 | 0.159 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.930984e-01 | 0.159 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.930984e-01 | 0.159 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.930984e-01 | 0.159 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.930984e-01 | 0.159 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.930984e-01 | 0.159 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.999918e-01 | 0.155 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.045838e-01 | 0.152 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.045838e-01 | 0.152 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.045838e-01 | 0.152 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.045838e-01 | 0.152 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.045838e-01 | 0.152 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.061729e-01 | 0.151 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.120667e-01 | 0.147 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.156401e-01 | 0.145 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.156401e-01 | 0.145 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.156401e-01 | 0.145 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.156401e-01 | 0.145 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.156401e-01 | 0.145 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.156401e-01 | 0.145 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.156401e-01 | 0.145 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.156401e-01 | 0.145 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.156401e-01 | 0.145 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.158805e-01 | 0.145 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.203970e-01 | 0.142 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.235565e-01 | 0.141 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.235565e-01 | 0.141 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.250318e-01 | 0.140 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.262832e-01 | 0.139 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.262832e-01 | 0.139 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.262832e-01 | 0.139 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.262832e-01 | 0.139 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.262832e-01 | 0.139 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.342659e-01 | 0.134 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.365286e-01 | 0.133 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.365286e-01 | 0.133 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.396101e-01 | 0.131 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.463911e-01 | 0.127 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.463911e-01 | 0.127 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.463911e-01 | 0.127 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.463911e-01 | 0.127 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.463911e-01 | 0.127 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.510216e-01 | 0.124 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.558850e-01 | 0.122 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 7.558850e-01 | 0.122 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.565596e-01 | 0.121 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 7.650241e-01 | 0.116 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.650241e-01 | 0.116 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.650241e-01 | 0.116 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.650241e-01 | 0.116 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.658478e-01 | 0.116 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.734048e-01 | 0.112 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.738215e-01 | 0.111 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.738215e-01 | 0.111 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.738215e-01 | 0.111 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.738215e-01 | 0.111 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 7.738215e-01 | 0.111 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.738215e-01 | 0.111 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.746015e-01 | 0.111 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.822901e-01 | 0.107 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.840808e-01 | 0.106 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.904421e-01 | 0.102 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.904421e-01 | 0.102 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.982894e-01 | 0.098 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.982894e-01 | 0.098 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.982894e-01 | 0.098 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 7.982894e-01 | 0.098 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.058432e-01 | 0.094 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.058432e-01 | 0.094 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.058432e-01 | 0.094 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.058432e-01 | 0.094 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.131146e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.190277e-01 | 0.087 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.190277e-01 | 0.087 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.201142e-01 | 0.086 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.201142e-01 | 0.086 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.201142e-01 | 0.086 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.242025e-01 | 0.084 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.242025e-01 | 0.084 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.268519e-01 | 0.083 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.268519e-01 | 0.083 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.268519e-01 | 0.083 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.268519e-01 | 0.083 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.333377e-01 | 0.079 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.333377e-01 | 0.079 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.333377e-01 | 0.079 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.333377e-01 | 0.079 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.333377e-01 | 0.079 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.333377e-01 | 0.079 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.333377e-01 | 0.079 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.333377e-01 | 0.079 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.333377e-01 | 0.079 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.333377e-01 | 0.079 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.333377e-01 | 0.079 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.395810e-01 | 0.076 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.395810e-01 | 0.076 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.435958e-01 | 0.074 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.455907e-01 | 0.073 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.487849e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.513756e-01 | 0.070 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.513756e-01 | 0.070 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.569442e-01 | 0.067 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.577495e-01 | 0.067 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.623044e-01 | 0.064 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 8.674641e-01 | 0.062 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.752681e-01 | 0.058 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 8.766663e-01 | 0.057 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.792392e-01 | 0.056 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.818136e-01 | 0.055 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.818136e-01 | 0.055 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.818136e-01 | 0.055 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 8.862433e-01 | 0.052 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.883394e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.905073e-01 | 0.050 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.962484e-01 | 0.048 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.985625e-01 | 0.046 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.095495e-01 | 0.041 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.162058e-01 | 0.038 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.162058e-01 | 0.038 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.193482e-01 | 0.037 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.205087e-01 | 0.036 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.223729e-01 | 0.035 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.223729e-01 | 0.035 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.242628e-01 | 0.034 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.252844e-01 | 0.034 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.252844e-01 | 0.034 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.252844e-01 | 0.034 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.280869e-01 | 0.032 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.280869e-01 | 0.032 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.307844e-01 | 0.031 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.333809e-01 | 0.030 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.358802e-01 | 0.029 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.358802e-01 | 0.029 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.358802e-01 | 0.029 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.382858e-01 | 0.028 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.418976e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.428301e-01 | 0.026 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.428301e-01 | 0.026 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.437634e-01 | 0.025 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.449754e-01 | 0.025 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.463361e-01 | 0.024 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.480042e-01 | 0.023 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.490278e-01 | 0.023 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.496227e-01 | 0.022 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.502705e-01 | 0.022 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.509409e-01 | 0.022 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.509409e-01 | 0.022 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.544547e-01 | 0.020 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.545546e-01 | 0.020 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.570202e-01 | 0.019 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.610042e-01 | 0.017 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.624684e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.624684e-01 | 0.017 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.624684e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.624684e-01 | 0.017 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.638777e-01 | 0.016 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.672456e-01 | 0.014 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.690060e-01 | 0.014 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.712907e-01 | 0.013 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.759441e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.771844e-01 | 0.010 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.788907e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.796613e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.832073e-01 | 0.007 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.832073e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.850312e-01 | 0.007 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.883666e-01 | 0.005 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.943073e-01 | 0.002 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.951934e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.959603e-01 | 0.002 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.965431e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.967476e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.972347e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.983858e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.986683e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.987670e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.995807e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999130e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999317e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999518e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999894e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999940e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999956e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999981e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |